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Abstract 
 
G protein-coupled receptors (GPCRs), the largest family of membrane proteins on the cell surface, play 
essential roles in signal transduction in all eukaryotic organisms. These proteins are responsible for 
sensing and detecting a wide range of extracellular stimuli and translating them to intracellular responses. 
This signaling requires a tight control for receptor activation without which abnormal signal leads to 
diseases. In fact, malfunctions of these receptors are associated with numerous pathological conditions 
and currently an estimated 40-50% of therapeutic drugs are designed to target these receptors suggesting 
that further increases in understanding of GPCRs and the signaling pathways they initiate will lead to new 
and more specific drug targets. We have used Saccharomyces cerevisiae GPCR Ste2p as a model system 
to understand structure-function relationships of these receptors. In this study, the role of the extracellular 
N-terminus has been examined using various biophysical methods with the anticipation to uncover its role 
in receptor function. It was found that some residues in the extracellular N-terminus were not accessible 
to a sulfhydryl reagent and that the alternating pattern of accessibility is consistent with the structure of a 
beta strand. This beta strand was found to be involved in dimer formation. Moreover, a conserved 
tyrosine residue in the middle of the beta strand was found to interact with two residues in the 
extracellular loop 1. It was also found that the N-terminus is involved in negative regulation and 
important for cell surface expression.  
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Chapter 1  
General introduction 
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G protein-coupled receptors: an overview 
Signal transduction is an essential biological process that is required to maintain cellular 
homeostasis and coordinated cellular activity in all organisms. The membrane proteins at the cell 
surface play crucial roles in these fundamental processes of communicating between the external 
and internal environment of the cell. The largest and most diverse membrane protein family on 
the cell surface is the G protein-coupled receptors (GPCRs) that are involved in nearly all 
important physiological processes in eukaryotic organisms (1). These proteins function by 
sensing an astonishing variety of extracellular signals, including photons, protons, ions, odorants, 
amino acids, nucleotides, steroids, fatty acids, proteins and peptides (2).  
The GPCR family of proteins comprises approximately 4% of the encoded human genes 
corresponding to over 800 members (1,3-5). Modifications in the signaling of these receptors are 
pertinent for many pathological conditions including cardiovascular and pulmonary diseases, 
pain perception, obesity, cancer, and neurological disorders (1,6,7). In fact, GPCRs are 
considered one of the most successful therapeutic targets with more than 25% of all modern 
prescription drugs targeting these receptors (8-12). However, only a very small fraction of the 
known GPCRs are therapeutic targets. Many GPCRs remain ‘orphan’, which have not been 
assigned either ligands and/or functions.  Even for many receptors whose ligands are known, 
there is a need for identifying alternate agonist and antagonist ligands. Regarding these facts, it is 
suggested that GPCRs will continue to be important drug targets of the future (1,13-15). Thus, 
the studies of GPCRs will contribute significantly to the understanding and treatment of a variety 
of diseases.  
GPCRs share a common structural organization with an extracellular N-terminus, seven 
transmembrane domains connected by extracellular and intracellular loops, and a cytoplasmic C-
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terminus (16-18). Despite the astounding diversity of their ligands, biological function and lack 
of strong sequence similarity, all GPCRs share common mechanisms of signal transduction. i.e.,   
they couple the binding of ligands to the activation of specific heterotrimeric guanine nucleotide-
binding proteins (G proteins) and/or non-G protein mediated signaling, leading to the modulation 
of downstream effector proteins and gene expression (19-22).  
Figure 1.1. Cartoon of a GPCR showing the seven transmembrane domains connected by 
alternating extracellular and intracellular loops. Agonist-binding activates the receptor 
triggering the exchange of GDP by GTP at the Gα subunit of the heterotrimeric G protein. 
This results in dissociation of the Gβγ from the Gα. Both GTP-bound Gα and the released 
GβƔ can mediate the stimulation or inhibition of intracellular effector proteins.  (Taken 
from (23)) 
Upon ligand binding, the receptor induces a conformational change in the intracellular 
heterotrimeric G proteins that act as molecular switch leading to intracellular responses. The G 
proteins are composed of three subunits (α, βγ dimer). For many GPCRs, activation leads to 
exchange of GDP by GTP on the Gα-subunit triggering the dissociation of the α-subunit from the 
receptor and the βγ dimer (24). Both the GTP bound α-subunit and the released βγ-dimer can 
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mediate the stimulation or inhibition of effector proteins such as enzymes and ion channels [e.g, 
adenylate cyclase, guanylyl cyclase, phospholipase C, mitogen-activated protein kinases 
(MAPKs), Ca+2, and K+ channels]. Thus, stimulation of GPCRs with specific agonists results in 
changes in the concentration of second-messenger molecules (24). However, this general 
mechanism of signal transduction by GPCRs may be different in yeast. 
Classification of GPCRs 
 
GPCRs have been organized into groups or classes based on different criteria including 
how their ligand binds, as well as physiological and structural features of the receptors. The most 
commonly used systems classify the GPCRs into 6 clans A, B, C, D, E, and F to include all 
GPCRs in animals and fungi based on sequence similarity in their transmembrane domains 
(25,26). Each clan is again divided into families based on common biochemical properties 
(Table 1.1). Human GPCRs have been recently classified into five families using a GRAFS 
(Glutamate, Rhodopsin, Adhesion, Frizzled/taste2, Secretin) system that is based on 
phylogenetic relationship in the transmembrane regions: rhodopsin (clan A), secretin (clan B), 
glutamate (clan C), adhesion, and frizzled/taste2 receptor families (4). Additionally, some 
GPCRs in humans could not be classified into any of the families, as sequences were very 
divergent. However, the other receptors clearly form five families as determined by the extensive 
phylogenetic analyses. Members of four of the five families all have long N termini. The 
exception is the members of the rhodopsin family; most members of the rhodopsin family have 
short N-termini, however there are instances of members with long N-terminal domains.  
The rhodopsin family (class A) has the largest number of receptors. Currently, there are 
more than 700 receptors in this family as recognized by the IUPHAR database (International 
Union of basic and clinical PHARmacology, http://www.iuphar-db.org/) (27). The members of 
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the rhodopsin family share several characteristics. Most members of the rhodopsin family 
contain the NSxxNPxxY motif in transmembrane domain VII (TMVII), and the D(E)-R-Y(F) or 
“DRY” motif or at the border between transmembrane domain III (TMIII) and intracellular loop 
2 (IL2). The ligands for most of the rhodopsin receptors bind within a cavity between the TM 
regions (28). 
 
The receptors of the secretin family (class B – 55 receptors as recognized by the 
IUPHAR database (27)) bind large peptide ligands that share high sequence similarity and most 
often act in a paracrine manner. The N-termini of these receptors are long (∼60 and 80 amino 
acids), and contain conserved Cys-Cys bridges that are important for ligand binding. This family 
consists of peptide and neuropeptide hormone receptors, such the secretin, calcitonin (CALC), 
vasoactive intestinal peptide (VIP), glucagon (GCG), parathyroid hormone (PTH), and  pituitary 
adenylyl cyclase-activating protein (PACAP) receptors. 
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Table 1.1. Sequence-based groupings within the G-protein-coupled receptors 
Clan A: rhodopsin-like receptors 
 Family I Olfactory receptors, adenosine receptors, melanocortin receptors, and others 
 Family II Biogenic amine receptors 
 Family III Vertebrate opsins and neuropeptide receptors 
 Family IV Invertebrate opsins 
 Family V Chemokine, chemotactic, somatostatin, opioids, and others 
 Family VI Melatonin receptors and others 
Clan B: calcitonin and related receptors 
 Family I Calcitonin, calcitonin-like, and CRF receptors 
 Family II PTH/PTHrP receptors 
 Family III Glucagon, secretin receptors and others 
 Family IV Latrotoxin receptors and others 
Clan C: metabotropic glutamate and related receptors 
 Family I Metabotropic glutamate receptors 
 Family II Calcium receptors 
 Family III GABA-B receptors 
 Family IV Putative pheromone receptors 
Clan D: STE2 pheromone receptors 
Clan E: STE3 pheromone receptors 
Clan F: cAMP receptors and archaebacterial opsins 
 
Table adapted from Flower (29) 
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The glutamate receptor family (class C) consists of eight metabotropic glutamate 
receptors (GRM), two gamma-aminobutyric acid (GABA) receptors (GABAB1 GABAB2; 
functional GABA receptors contain both GABAB1 and GABAB2 subunits), a single calcium-
sensing receptor (CASR), three receptors that are believed to be taste receptors (TAS1) and 
seven orphan receptors (27). All receptors of this family contain long N-terminus.  In particular, 
the metabotropic glutamate receptors contain a very long N terminus (∼280 to 580 amino acids) 
that forms two distinct lobes separated by a cavity in which glutamate binds, forming the so-
called “Venus fly trap” where the glutamate causes the lobes to close around the ligand. The 
CASR also has a long, cysteine-rich N terminus, which is important for mediating calcium 
signaling, although it is not known if it is involved in Ca
2+
 binding. The GABA receptors have a 
long N-terminus that contains the ligand-binding site but lacks the cysteine-rich domain found in 
the other receptors of this family. The TAS1 receptors are expressed in the tongue and believed 
to mediate taste signals. These receptors also have a long N terminus with a series of conserved 
Cys residues. 
The members of the adhesion family of GPCRs contain N-termini of variable length 
(~200 to ~2800 amino acids) and are often rich in glycosylation sites and proline residues. The 
long N-termini of these GPCRs contain motifs that are likely to participate in cell adhesion 
(30,31).  
 The frizzled/taste2 receptor family includes two groups: the frizzled and the TAS2 
receptors. There are several consensus motifs (IFL in TMII, SFLL in TMV, and SxKTL in 
TMVII) in the members of this family which are not found in the other four families. The TAS2 
receptors are expressed in the tongue and palate epithelium, and are believed to function as bitter 
taste receptors (4). These receptors have a very short N terminus that is unlikely to contain a 
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ligand-binding domain. Members of the frizzled family of receptors have a long N-terminus 
(~200-amino acid) with conserved cysteines that are believed to be involved in ligand binding. 
The receptors of this family are responsible for controlling cell fate, proliferation, and polarity 
during metazoan development (4,32,33). Like other eukaryotic organisms, fungi also possess 
GPCRs that are responsible for sensing extracellular signals. Fungal GPCRs are described later 
in a separate section. 
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GPCR Crystal Structures 
 
Structural information for GPCRs is vital to understand how these signaling molecules 
carry out their function.  This information is also essential for drug design and development. 
Although structures of a number of GPCRs have been obtained, information about the structure-
function relationships of GPCRs is still in its infancy. (34-36). The methods available for use to 
gain structural information of proteins include X-ray crystallography, electron microscopy or 
diffraction, NMR spectroscopy and molecular modeling. All of these methods require high 
concentrations of purified protein. Additionally, crystallization and NMR require proteins in 
media that provide a good environment for study. In order to maintain their native structures, 
membrane proteins are required to be maintained in a lipid-like environment making the 
structural studies by crystallization and NMR more challenging. In fact, crystallization of GPCRs 
was one of the most challenging subjects in structural biology due to the poor natural abundance 
and high intrinsic flexibility of these membrane proteins. Bovine rhodopsin was the first GPCR 
to be crystallized about a decade ago by Palczewski et al (37). However, it took several years to 
solve the crystal structure of a second GPCR (beta 2 adrenergic receptor) in 2007 (38,39). Since 
then there has been almost an exponential growth in the number of solved structures due to the 
application of several innovative protein engineering techniques and crystallography methods. 
Currently there are 75 crystal structures of 18 GPCRs that have been solved (see Table 1.2) 
adapted from Maeda 2013) (40). These structures provide insights into the structural and 
functional diversity of these receptors and will be helpful to discover the molecular signatures of 
the GPCRs. These structures will also aid in understanding the molecular changes that occur 
during receptor activation. The structural data combined with data from the biophysical, 
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biochemical and computational studies will allow us to understand the structure-function 
relationships of GPCRs.  
Due to the tremendous diversity of GPCRs and their involvement in so many pathways in 
the cell, there remains a huge potential for the development of drugs to ameliorate many diseases 
including neurological disorders, inflammatory diseases, cancer and metabolic imbalances. 
Therefore, structures of more GPCRs and understanding the molecular mechanism of receptor 
activation is important for fundamental biology as well as for improving human health by 
facilitating structure-based in-silico drug discovery and the development of drugs with improved 
specificity and pharmacodynamics. 
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Table 1.2. GPCR structures solved in the 2000-2013 period 
GPCR Species Year PDB code Reference 
Rhodopsin Bovine 2000 1F88 (37) 
1 Adrenergic Turkey 2008 2VT4 (41) 
2 Adrenergic Human 2007 2R4R (38) 
D3 dopamine Human 2010 3PBL (42) 
H1 histamine Human 2011 3RZE (43) 
M2 muscarinic acetylcholine Human 2012 3UON (44) 
M3 muscarinic acetylcholine Rat 2012 4DAJ (45) 
A2A_Adenosine Human 2008 3EML (46) 
Chemokine CXCR4 Human 2010 3ODU (47) 
Chemokine CXCR1 Human 2012 2LNL (48) 
-Opioid Mouse 2012 4DKL (49) 
-Opioid Human 2012 4DJH (50). 
-Opioid Mouse 2012 4EJ4 (51) 
N/OFQ opioid Human 2012 4EA3 (52) 
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Table 1.2 continued 
GPCR Species Year PDB code Reference 
Neurotensin 
receptor 
Rat 2012 4GRV (53) 
PAR1 Human 2012 3VW7 (54) 
Sphingosine 
1-phosphate 
Human 2012 3V2W (55) 
Smoothened  Human 2013 4JKV (56) 
Serotonin 5-
HT1B 
Human 2013 4IAR (57) 
 
Table adapted from Maeda (40). 
Fungal GPCRs 
 
 Like many other eukaryotic organisms, fungi also possess GPCRs that respond to 
extracellular signals to ensure proper cellular response. Although many GPCRs have been 
identified in different fungi, only a few were included in the GPCR classification system (A-F 
system, Table 1.1) described in the previous section (29). As a result, the fungal GPCRs have 
been categorized separately into six classes based on sequence homology and ligand sensing 
(Table 1.3). These are Ste2p-like pheromone receptors, Ste3p-like pheromone receptors, 
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carbon/amino acid receptor, putative nutrient receptor, cAMP receptor-like, and microbial opsin 
(22).  
Although a number of GPCRs have been identified in fungi based on conserved 
sequences and structures, only a few are well studied. Specifically the Saccharomyces cerevisiae 
mating pheromone receptors Ste2p and Ste3p have been studied more extensively than the other 
GPCRs due to the availability of whole genome sequence and the ability to manipulate easily. In 
fact, the studies on S. cerevisiae GPCR system have considerably advanced our understanding 
the mating system at molecular level.  
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Table 1.3. Six classes of GPCRs in fungi 
Species 
Ste2-like 
pheromo
ne 
receptor 
Ste3-like 
pheromo
ne 
receptor 
Carbo
n/amin
o acid 
recepto
r 
Putative 
nutrient 
receptor 
cAMP 
receptor-
like 
Microbial 
Opsin 
 Saccharomyces 
cerevisiae 
Ste2 Ste3 Gpr1 
SCRG_01312 
SCRG_02823 
SCRG_00179 
– – 
 Schizosaccharo
myces pombe 
Mam2 Map3 Git3 Stm1 – – 
 Candida 
albicans 
Ste2 Ste3 Gpr1 
CAWG_02899 
CAWG_06059 
CAWG_02686 
– – 
 Aspergillus 
nidulans 
GprA GprB 
GprC 
GprD 
GprE 
GprF GprG 
AN5720 
GprH 
GprI 
AN8262 
AN3361 
 Aspergillus 
fumigatus 
Afu3g143
30 
Afu5g078
80 
Afu7g0
4800 
Afu5g04100 
Afu1g06840 
Afu1g11900 
Afu3g017
50 
Afu5g041
40 
Afu3g007
80 
Afu7g014
30 
 Neurospora 
crassa 
Pre-2 Pre-1 Gpr-4 Gpr-5 Gpr-6 
Gpr-1 
Gpr-2 
Gpr-3 
Nop-1 
ORP-1 
 Magnaporthe 
grisea 
MGG_04
711 
MGG_06
452 
MGG_
08803 
MGG_04698 
MGG_02855 
MGG_06
738 
MGG_090
15 
 Cryptococcus 
neoformans 
– 
Ste3α/Ste
3a Cpr2 
Gpr4 Gpr2 Gpr3 
Gpr4 
Gpr5 
CNAG_03
572 
(Ops1) 
 Ustilago maydis – Pra1 Pra2 – 
UM06006 
UM01546 
UM03423 
UM02629 
UM04125 
 Coprinopsis 
cinerea 
– 
Rcb1 
Rcb2 
Rcb3 
CC1G_02
129 
– 
CC1G_07132 
CC1G_04180 
CC1G_02
288 
CC1G_02
310 
– 
 
 
Table adapted from Xue et. al. (22) 
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S. cerevisiae GPCRs 
 
GPCR studies using mammalian systems can be extremely complex due to cross-talk 
between different types of receptors and the assortment of G proteins present that can regulate 
multiple pathways. In constrast, the unicellular, genetically tractable eukaryotic organism S. 
cerevisiae provides a simple biological system with only a few GPCRs and G proteins (58,59). S. 
cerevisiae has only three GPCRs: Ste2p, Ste3p and Gpr1p. Ste2p and Ste3p are mating 
pheromone receptors and Gpr1p is a carbohydrate sensor. Although the pheromone and the 
carbohydrate sensing receptors share some downstream components, no cross-talk occurs 
between these two receptor systems as they couple to two different G proteins. The mitogen-
activated protein kinase (MAPK) pathway activated by the GPCRs of this organism exhibits high 
homology to that of the mammalian system (60). In spite of little sequence similarity to the 
endogenous yeast GPCRs, several mammalian GPCRs were successfully expressed in yeast and 
were capable of activating the MAPK pathway (59,61,62). Yeast GPCRs have also been shown 
to exhibit signaling when expressed in mammalian cells (63).  
16 
 
S. cerevisiae exists as a haploid or diploid cell (64). The haploid cells exist as one of two 
mating types, MATa and MATα, which are distinguished by the expression of a set of genes 
involved in mating that are not expressed by the diploids. MATa cells express the GPCR Ste2p 
and the pheromone a-factor, a hydrophobic, farnesylated, carboxymethylated, dodecapeptide 
with the sequence YIIKGVFWDPAC(Farnesyl)-OCH3. MATα cells express the GPCR Ste3p 
and the pheromone α-factor, a tridecapeptide with the sequence WHWLQLKPGQPMY. The 
pheromones a- and α-factor, bind to Ste3p and Ste2p, respectively, initiating the mating and 
eventual fusion of the two haploid cells resulting in a diploid cell (Figure 1.2). Pheromone 
binding causes a conformational change in the receptor that triggers the activation of the 
intracellular heterotrimeric G proteins consisting of Gpa1p (Gα), Ste4p (Gβ) and Ste18p (Gγ) 
leading to the G1 cell cycle arrest, polarized growth, dissolution of the cell wall and membranes  
followed by cellular fusion (65).  Receptor activation triggers the exchange of GDP with GTP at 
Gpa1p (Gα) subunit releasing the Ste4p/Ste18p (Gβγ) dimer which in turn transmits the signal 
required for mating.  The Gpa1p (Gα) may also promote signaling via the RNA binding protein 
17 
 
Scp160, although the mechanism is unknown (66).
 
Figure 1.2. Pheromone mediated mating in Saccharomyces cerevisiae. Schematic 
representation of the pheromone/receptor mediated communication between MATa and 
MATα haploid cells prior to mating. The α-factor pheromone expressed by the MATα cells 
binds with Ste2p expressed on the cell surface of MATa cells. The a-factor pheromone 
expressed by the MATa cells binds with Ste3p expressed on the cell surface of MATα cells. 
Pheromone binding activates the receptors resulting in initiation of signaling involving the 
MAP kinase cascades, and activation of mating specific genes ultimately resulting in the 
fusion of the two haploid cells. 
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The Ste4p/Ste18p complex transmits the signal to a mitogen-activated protein (MAP) 
kinase cascade through at least three effector proteins: (i) Ste20, a p21-activated protein kinase, 
(ii) Ste5, a scaffold protein that coordinates the MAPK pathway, and (iii) Far1, a protein 
involved in cell cycle control (65,67-69). Ste20 phosphorylates and activates Ste11 (MAPKKK), 
the first kinase in the MAPK pathway, which in turn drives a series of phosphorylation reactions 
involving Ste7 (MAPKK) and Fus3 (MAPK) (70,71). Phosphorylated Fus3 activates Ste12, the 
transcription factor required for the expression of mating genes. Fus3 also phosphorylates and 
inactivates Dig1 and Dig2, two negative regulators of the transcription factor Ste12 (65,72).  The 
scaffold protein Ste5p serves to facilitate interactions among Ste11, Ste7 and Fus3 and delivers 
these proteins to the plasma membrane via its associated G protein  subunit (73-75).  In 
addition, Ste5 has been shown to also limit cross-talk between alternative MAPK signaling 
pathways. Ste5 increases the affinity of Ste7 for Fus3 over Kss1 during response to pheromone. 
Ste7 preferentially targets the Kss1 kinase during filamentous growth (e.g., upon nitrogen 
starvation) (76). Fus3 phosphorylates and activates Far1 (72), which inhibits Cdc28-G1 cyclin 
complex thereby promoting cell cycle arrest (77). The transcriptional transactivator Ste12p binds 
to the pheromone response element (PRE) at the promoter region of target genes such as FUS1, 
FUS2, FIG1, FIG2, and AGA1 that are induced for cell fusion (78). The two haploid cells of the 
opposite mating types form  shmoos, (79) followed by degradation of the cell wall, plasma 
membrane and finally fusion of their nuclei to become one a/α diploid zygote (80). 
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Figure 1.3. Schematic diagram of the mating MAPK signaling cascade in S. cerevisiae. 
Activation of the pheromone receptor after binding with pheromone (α-factor) leads to the 
exchange of GDP with GTP in the G protein α subunit (Gpa1). This results in dissociation 
of Gα from the G protein βγ subunits (Ste4 and Ste18). Free βγ activates a downstream 
signaling cascade through the guanine nucleotide exchange factor Cdc24, the protein 
kinase Ste20, and the kinase scaffold protein Ste5. The MAP kinase Fus3 phosphorylates 
and activates the transcription factor Ste12, resulting in new gene transcription 
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Like many other eukaryotic GPCRs, the mating pathway in yeast is highly regulated by 
several mechanisms. The extracellular protease Bar1p produced by the MATa cell cleaves α-
factor (81) allowing the cells to recover from α-factor induced growth arrest. Sst2p, a member of 
the regulator of G-protein signaling (RGS) protein family, interferes with GTP-bound Gpa1p and 
down-regulates mating signal (82). Yeast casein kinases, Yck1p and Yck2p, are involved in 
budding morphogenesis and internalization of pheromone receptors (83). Yck-mediated 
phosphorylation of the mating receptors is required for vesicle trafficking at the cell membrane 
(84). Eventually phosphorylation at the C-terminus of the receptor leads to ubiquitination, 
internalization and degradation (85).  
Taking advantage of the simplicity of the yeast system and the power of yeast genetics 
along with the low cost of yeast cell culture, the yeast GPCR system have enabled many 
researchers worldwide to use it as a model for structure-function analysis of GPCRs.  Moreover, 
yeast GPCRs in a haploid cell can replaced with a mammalian GPCR and the mating pathway 
can be activated. Heterologous expression of mammalian GPCRs in a yeast host has enabled 
researchers to develop cell-based functional assays in a eukaryotic system free from cross-talk 
with other GPCRs and can be used for ligand identification and pharmacological characterization 
(59,61,63). 
The use of Ste2p as a model GPCR 
 
Ste2p, the α-factor pheromone receptor of S. cerevisiae, shares common architectural 
organization of GPCRs with the signature seven transmembrane domains. Although there is no 
significant sequence homology across the members of the GPCR superfamily, their mechanism 
of signal transduction is thought to be similar. In fact, comparative analysis of two widely 
divergent GPCRs, Ste2p (a Class D GPCR) and rhodopsin (a Class A GPCR) exhibited several 
21 
 
similarities (20). For example, ligand binding occurs within the core of the 7TM helices (86-88); 
the third intracellular loop plays key roles in G protein activation (89-91);.and the C-terminus is 
the target for desensitization by phosphorylation and ligand-mediated down-regulation by 
receptor endocytosis (92,93). In addition, conserved residues important for receptor function are 
located in TM1 and TM3 of both receptors. Strongly polar amino acids in Ste2p that mediate 
helix interactions are also located in similar positions in rhodopsin. Mutation of these residues 
leads to phenotypic changes such as loss of function or constitutive activity.  In both receptors, 
small and weakly polar amino acids located in identical positions (TM domains) facilitate tight 
helix packing. Location of conserved amino acids and sites of constitutively active mutations are 
located in TM3, TM6 and TM7. Proline is essential at similar positions in TM6 and TM7. Thus 
these structure-function similarities provide strong support that the underlying mechanism of 
signal transduction in these receptors is similar.  
 Although there has been an explosion of X-ray crystal structures of GPCRs since 2007, 
X-ray crystallography of Ste2p is still not possible due to difficulties in obtaining sufficient 
amount of pure protein. As a result, structure-function information of Ste2p has been mainly 
obtained by mutational analysis. Substituted Cysteine Accessibility method (SCAM), modeling, 
and biophysical analysis have been used in several studies to obtain structural information for 
Ste2p. A recent study using SCAM proposed that the N-terminus has a β-strand between residues 
20-30 and that this β-strand participates in homodimer formation (94). Another study using 
SCAM by Hauser et al. proposed that residues 106-114 in the EL1 form a 310 helix (95). More 
details describing the N-terminus and its role in dimerization of Ste2p will be discussed in 
chapter 2 of this dissertation. Modeling and biophysical studies by Akal-Strader et. al. predicted 
that the C-terminus of the EL1 comprising residues 126-135 contain two short β-strands (96). 
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The solvent accessibility of the several residues were also reported to change in a ligand-
dependent manner. Hauser et. al. proposed that part of the EL1 is buried in a solvent-inaccessible 
environment and that this part interacts with the extracellular part of the transmembrane domains 
5 and 6. Choi and Konopka (97) used SCAM to determine the TM boundaries. They proposed 
that TM domains of Ste2p vary in length and that some TM domains are tilted relative to the 
plane of the membrane in a manner similar to that described in the crystal structure of rhodopsin.   
 Ste2p is activated upon binding to the α-factor pheromone (WHWLQLKPGQPMY), a 13-
residue peptide. Analysis of α-factor using alanine scanning mutagenesis studies indicated that 
residues near the N-terminus (Trp
1
-Leu
4
) of this peptide are involved in receptor activation and 
signal transduction, while residues near the C-terminus (Gln
10
-Tyr
13
) are associated with ligand 
binding (58,98). The central region consisting of residues Lys
7
-Gln
10
 assumes a -turn structure 
that has been shown to be critical for proper orientation of the signaling and the binding domains 
of the peptide (99-101). It was also demonstrated that deletion of the last two residues 
(Met
12
Tyr
13
) from the peptide results in a peptide that does not show any significant binding and 
does not block the binding of the full-length 13-residue peptide, but instead enhances the activity 
the intact peptide. It was demonstrated that this 11-residue peptide (WHWLQLKPGQP) enhances 
the signaling activity of Ste2p when it is added to the wild type thereby acting as a synergist (102). It 
was also shown that deletion of the N-terminus results in a peptide that lowers the signaling activity 
of the full-length pheromone thereby acting as an antagonist (103). Thus studies with -factor 
suggested that three regions of the peptide plays three different roles, each being dedicated to a 
certain function.  
Cross-linking studies using unnatural amino acid p-benzoylphenylalanine (Bpa) at various 
positions of -factor indicated that residues Trp1, Trp3, Gln5 and Tyr13 residues of -factor interact 
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with residues at the extracellular ends of TM5-TM7 and portions of EL2 and EL3 close to these TMs 
(104). Several studies indicated that Tyr13 of -factor may interact directly with a region of Ste2p 
(Phe55-Arg58) at the extracellular end of TM1 (86,104,105). In studies using alanine scanning 
mutagenesis, Lee et al. showed that Tyr266 in the extracellular end of TM6 may be part of the 
ligand-binding pocket.  Tyr266 recognizes the N-terminal portion of -factor, and upon ligand 
binding is involved in the transformation of Ste2p into an activated state (106). Later, Tyr266 was 
shown to interact with Asn205 (107,108). The 10th residue (Gln10) of -factor was shown to be 
adjacent to Ser47 and Thr48 of Ste2p (109). Studies by Bajaj et. al. using a fluorescent alpha-factor 
analogue fluorescent α-factor analogue [K7(NBD),Nle12]α-factor in conjunction with flow 
cytometry and fluorescence microscopy suggested that the -factor binds to the receptor in a two-
step process: an initial interaction in which the ligand is placed in a hydrophobic environment 
followed by a conversion to a state in which the ligand moves to a more polar environment (110). 
Based on these studies a model of ligand binding to the receptor was suggested by our lab (58). 
According to this model, the α-factor bends around the Gly9-Gln10-Pro11 residues and carboxyl 
terminal residues Gln10-Pro11-Met12-Tyr13 side chains of α-factor interact with TM1 of the receptor. 
while the N-terminal residues Trp1 and Trp3 side chains interact with a pocket formed by TM6-
ECL3-TM7. (58). 
Interactions among proteins play essential roles in the organization and function of 
cellular signaling. GPCRs have been considered to exist and function as monomers for many 
years. However, an increasing number of studies demonstrated that GPCRs are able to form 
dimers or higher order oligomers. Several studies reported that dimerization and /or 
oligomerization are often essential for modulation of receptor function (Table 1.4) (10,111-117).  
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Table 1.4. Proposed roles of GPCR dimerisation/oligomerisation 
Role of dimerisation/ 
oligomerisation 
Receptor(s) References 
Protein folding β2-adrenoceptor (118) 
CXCR1 (119) 
α2-adrenoceptors (120) 
TSH receptor (121) 
Frizzled 4 (122) 
Calcium sensing receptor (123) 
Melacortin-1 receptor (124) 
CXCR1–CXCR2 hetero-dimer (119) 
Efficient signal transduction Rhodopsin (125,126) 
BLT1 leukotriene B4 receptor (127) 
G-protein selectivity (hetero-
dimers) 
MOP and DOP receptors (128,129) 
D1 and D2 dopamine 
receptors 
(130,131) 
Signal alteration/modulation 
(hetero-dimers) 
Orexin-1 receptor and 
cannabinoid CB1 
(132) 
Melatonin MT1 and GPR50 (133) 
MrgD and MrgE (134) 
DOP receptor and SNSR-4 (135) 
Somatostatin sst2a and sst3 (136) 
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Table 1.4 continued 
Role of dimerisation/ 
oligomerisation 
Receptor(s) References 
Control of physiological 
function (heterodimers) 
DOP and KOP receptors (137) 
Angiotensin AT1 and 
Bradykinin B2 
(138,139) 
Angiotensin AT1 and Mas (140,141) 
EP1 prostanoid receptor and 
β2-adrenoceptor 
(142) 
Various adenosine and 
dopamine receptors 
(143-146) 
Adenosine A1 and A2A (147) 
Dopamine D2 and 
cannabinoid CB1? 
(148) 
 
Table adapted from Milligan 2007 (111). 
Ste2p has also been identified in oliogmers in intact cells and membranes, although the 
functional significance of this oligomerization/dimerization is not clear. Gehret et. al. (149) used 
bioluminescence resonance energy transfer (BRET) to demonstrate that co-expressed Ste2p 
tagged with Renilla luciferase or a modified green fluorescent proteins co-oligomerize. Their 
study indicated that individual receptors that form oligomers do not act independently. In an 
analysis of Ste2p mutants using fluorescence resonance energy transfer (FRET) Overton and 
Blumer (150) demonstrated that the N-terminus, TM1 and TM2 mediate oligomerization of 
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Ste2p. Another study used disulfide cross-linking to demonstrate that TM1 and TM4 are dimer 
interfaces of Ste2p (151). These two transmembrane domains have also been reported to be 
dimer contacts in rhodopsin, a class A GPCR, providing evidence that structure and function are 
highly conserved across GPCRs (151).  A study by Kim et. al. demonstrated that TM1 and TM7 
of Ste2p also participate in dimerization. They demonstrated that the dimers formed by TM7 
changes upon receptor activation (152). More recently, Umanah et al. demonstrated that IL3 of 
Ste2p also participates in the dimerization (153). Uddin et al. (94) demonstrated that the N-
terminus of Ste2p also participates in Ste2p dimerization. Thus, several domains of Ste2p have 
been found to be associated with oligomerization/dimerization, although the precise, functional 
significance of this observation still unclear. In chapters 2, 3 and 4 of this dissertation, 
dimerization of Ste2p is discussed in more detail. 
This dissertation describes the role of extracellular N-terminus of Ste2p and its 
interaction with extracellular loop 1. In Chapter 2, substituted Cysteine Accessibility Method 
(SCAM) was used to determine the solvent accessibility of the N-terminus. This chapter also 
discusses the possible structure of the N-terminus and its role in receptor dimerization. Chapter 3 
describes the role of the N-terminus in receptor function. The interaction between the N-terminus 
and the extracellular loop 1 is discussed in Chapter 4. Finally, Chapter 5 is an overall evaluation 
of these studies and future directions. This experimental results presented in this dissertation will 
provide a better understanding of the structure of the N-terminus of Ste2p and how this structure 
plays a role in regulation of receptor function. Ultimately these studies will be aid in the 
understanding of structure-function relationships which regulate receptor signaling. 
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Abstract 
G protein-coupled receptors (GPCRs) are members of a superfamily of cell surface 
signaling proteins that play critical roles in many physiological functions; malfunction of these 
proteins is associated with multiple diseases. Understanding the structure-function relationships 
of these proteins is important, therefore, for GPCR-based drug discovery. The yeast 
Saccharomyces cerevisiae tridecapeptide pheromone α-factor receptor Ste2p has been studied as 
a model to explore the structure-function relationships of this important class of cell surface 
receptors. Although transmembrane domains of GPCRs have been examined extensively, the 
extracellular N-terminus and loop regions have received less attention. We have used the 
substituted cysteine accessibility method (SCAM) to probe the solvent accessibility of single 
cysteine residues engineered to replace residues Gly20 through Gly33 of the N-terminus of 
Ste2p. Unexpectedly, our analyses revealed that the residues Ser22, Ile24, Tyr26, and Ser28 in 
the N-terminus were solvent inaccessible, whereas all other residues of the targeted region were 
solvent accessible. The periodicity of accessibility from residues Ser22 to Ser28 is indicative of 
an underlying structure consistent with a -strand that was predicted computationally in this 
region. Moreover, a number of these Cys-substituted Ste2p receptors (G20C, S22C, I24C, Y26C, 
S28C and Y30C) were found to form increased dimers compared to the Cys-less Ste2p. Based on 
these data, we propose that part of the N-terminus of Ste2p is structured and that this structure 
forms a dimer interface for Ste2p molecules. Dimerization mediated by the N-terminus was 
affected by ligand binding indicating an unanticipated conformational change in the N-terminus 
upon receptor activation. 
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Introduction 
G protein-coupled receptors (GPCRs) belong to a superfamily of cell surface signaling 
proteins that play pivotal roles in many physiological processes including responses to hormones 
and neurotransmitters as well as being responsible for vision, olfaction and taste (1). Malfunction 
of GPCRs is associated with multiple diseases including Alzheimer’s, Parkinson’s, diabetes, 
color blindness, asthma, depression, hypertension, stress, cardiovascular, and immune disorders. 
Because these receptors are involved in a wide range of cellular functions, modulation of GPCR 
function is an important therapeutic goal with about 40-50% of drugs used in clinical medicine 
designed to affect GPCRs (2-4). Nonetheless, only a fraction of the GPCR superfamily is 
targeted by current drugs (5). 
To date detailed atomic-level structural information for seven GPCRs has been obtained 
(6-12). These crystal structures have played a crucial role in understanding the structure-function 
relationships of these receptors. However, further structural information for additional GPCRs is 
vital for a more comprehensive understanding of receptor function and ultimately for drug 
development (1, 2, 13). In addition, most of the studies have revealed structural information 
focused on the transmembrane domains, although a large portion of all GPCRs is composed of 
intracellular and extracellular loops as well as N- and C- termini.  These regions have received 
less consideration with respect to structural analysis because many of the crystals analyzed 
contained a large unnatural replacement within the third intracellular loop and the extracellular 
regions were not always visualized. It is generally believed that the loop regions and N- and C-
termini are flexible and all the residues in the extracellular domains are solvent accessible. 
However, accessibility analysis of extracellular loop 1 of Ste2p indicated that all extracellular 
residues are not accessible; and the accessibility of some residues changes upon receptor 
activation (14). Therefore, we decided that a rational first approach to studying the structure and 
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function of the N-terminus was to probe systematically its solvent accessibility by the substituted 
cysteine accessibility method (SCAM) so that we might uncover structural elements of the N-
terminus and their functional roles. Solvent accessibility determines whether particular Cys 
residues are in a hydrophilic or hydrophobic environment. Residues that face the low dielectric 
of the membrane or are located in tightly packed regions are inaccessible to a highly soluble, 
hydrophilic SCAM reagent. Conversely, Cys residues that react well with the reagent are 
predominantly exposed to a hydrophilic milieu outside the membrane or are not packed closely 
in a solvent excluding environment.   
We carried out Cys scanning mutagenesis of residues G20 to G33 of Ste2p and probed 
the solvent accessibility of the Cys residue in these mutant receptors using SCAM (15, 16). Our 
analysis revealed a periodicity of accessible residues in the N-terminus which supported the 
computational prediction of a β-strand in this portion of Ste2p. In addition, we observed that 
certain Cys residues in the N-terminus promoted dimer formation suggesting the involvement of 
a 14-amino acid region of the N-terminus in Ste2p dimerization.  
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Methods 
 
Media, Reagents, Strains, and Plasmids: S. cerevisiae strain LM102 [MATa ste2 FUS1-
lacZ::URA3 bar1 ura3 leu2 his4 trp1 met1] (17) was used for growth arrest, FUS1-lacZ gene 
induction and saturation binding assays, and the protease-deficient strain BJS21 [MATa, prc1-
407 prb1-1122 pep4-3 leu2 trp1 ura3-52 ste2::Kan
R
 (18) was used for protein isolation, SCAM 
and immunoblot analyses to decrease receptor degradation during analyses (19). The plasmid 
pBEC2 containing C-terminal FLAG™ and His-tagged STE2 (14) was transformed by the 
method of Geitz (20). Transformants were selected by growth on yeast media (21) lacking 
tryptophan (designated as MLT) to maintain selection for the plasmid. The cells were cultured in 
MLT and grown to mid log phase at 30°C with shaking (200 rpm) for all assays. 
 
Growth Arrest Assays: S. cerevisiae LM102 cells expressing Cys-less Ste2p and single Cys 
mutants were grown at 30°C overnight in MLT, harvested, washed three times with water, and 
resuspended at a final concentration of 5×10
6
cells/mL (22). Cells (1 mL) were combined with 
3.5 mL of agar noble (1.1%) and poured as a top agar lawn onto a MLT medium agar plate. 
Filter disks (BD, Franklin Lakes, NJ) impregnated with α-factor (2, 1, 0.5, 0.25 and 0.125 
µg/disk) were placed on the top agar. The plates were incubated at 30°C for 24h and then 
observed for clear halos around the disks. The experiment was repeated at least three times, and 
reported values represent the mean of these tests. 
 
FUS1-lacZ Gene Induction Assay: LM102 cells expressing Cys-less Ste2p and single Cys 
mutants were grown at 30 ºC in selective media, harvested, washed three times with fresh media 
and resuspended at a final concentration of  5 x 10
7
 cells/mL. Cells (500 µl) were combined with 
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α-factor pheromone (final concentration of 1μM) and incubated at 30ºC for 90 min. The cells 
were transferred to a 96-well flat bottom plate (Corning Incorporated, Corning, NY) in triplicate, 
permeabilized with 0.5% Triton X-100 in 25 mM PIPES buffer (pH 7.2) and then β-
galactosidase assays were carried out using fluorescein di-β-galactopyranoside (Molecular 
Probes, Inc., Eugene, OR) as a substrate as described previously (18, 23). The reaction mixtures 
were incubated at 37°C for 60 min and 1.0 M Na2CO3 was added to stop the reaction. The 
fluorescence of the samples (excitation of 485 nm and emission of 530 nm) was determined 
using a 96-well plate reader Synergy2 (BioTek Instruments, Inc., Winooski, VT). The data were 
analyzed using Prism software (GraphPad Prism version 5.03 for Windows, GraphPad Software, 
San Diego CA). The experiments were repeated at least three times and reported values represent 
the mean of these tests. 
Binding Assays: Tritiated [
3H] α-factor (9.33 Ci/mmol) prepared as previously described (24) 
was used in saturation binding assays on whole cells. LM102 cells expressing Cys-less or single 
Cys mutant of Ste2p were harvested, washed 3 times with YM1 (25), and adjusted to a final 
concentration of 3 × 10
7
cells/mL. Cells (600 µL) were combined with 150 µL of ice-cold 5X 
binding medium (YM1 plus protease inhibitors [YM1i ](25) supplemented with [
3H]α-factor and 
incubated at room temperature for 30 min. The final concentration of [
3H]α-factor ranged from 
0.5 × 10
−10 
to 1 × 10
−6 
M. Upon completion of the incubation interval, 200 µL aliquots of the 
cell-pheromone mixture were collected in triplicate and washed over glass fiber filter mats using 
the Standard Cell Harvester (Skatron Instruments, Sterling, VA). Retained radioactivity on the 
filter was counted by liquid scintillation spectroscopy. LM102 cells lacking Ste2p were used as a 
nonspecific binding control for the assays. Binding assays were repeated a minimum of three 
times, and similar results were observed for each replicate. Specific binding for each mutant 
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receptor was calculated by subtracting the nonspecific values from those obtained for total 
binding. Specific binding data were analyzed by nonlinear regression analysis for single-site 
binding using Prism software (GraphPad Software, San Diego, CA) to determine the Kd and Bmax 
values for each mutant receptor. 
 
Immunoblots: BJS21 cells expressing Cys-less or single Cys mutants grown in MLT were used 
to prepare total cell membranes isolated as previously described (25). Protein concentration was 
determined by BioRad  protein assay (BioRad, Hercules, CA)(14), and membranes were 
solubilized in sodium dodecyl sulfate (SDS) sample buffer (10% glycerol, 5% 2-
mercaptoethanol, 1% SDS, 0.03% bromophenol blue, 62.5 mM Tris, pH 6.8). For studies of 
disulfide cross-linking, membranes were solubilized in SDS sample buffer without 2-
mercaptoethanol. Proteins were fractioned by SDS−PAGE (10% acrylamide) along with pre-
stained Precision Plus protein standards (BioRad) and transferred to an ImmobilonTMP 
membrane (Millipore Corp., Bedford, MA). The blot was probed with anti-FLAG™ M2 
antibody (Sigma/Aldrich Chemical, St. Louis, MO), and bands were visualized with the West 
Pico chemiluminescent detection system (Pierce). The total intensity of all Ste2p bands in 
each lane was determined using a ChemiDoc XRS photodocumentation system with 
Quantity One one-dimensional analysis software (version 4.6.9, BioRad, Hercules, CA). 
Multiple repeats of immunoblot experiments yielded similar results. Constitutively-expressed 
membrane protein Pma1p was used as a loading control as described previously (26) using 
Pma1p antibody (Thermo Scientific, Rockford, IL). 
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Whole-cell MTSEA Labeling, Membrane Preparation, and Immunoblots: 
MTSEA-biotin (2-((biotinoyl)amino)ethyl methanethiosulfonate) (Biotium, Hayward, CA) 
labeling was performed as described previously (14). To eliminate reaction with native Cys in 
Ste2p, all the mutants were constructed in a Cys-less receptor background. This Cys-less 
receptor contained a FLAG™ epitope tag and a 6XHis tag at the C-terminus of the receptor. 
Experiments were completed at least three times as described below. BJS21 cells expressing 
single Cys mutations in Ste2p or Cys-less receptor were grown in MLT at 30°C overnight. Cells 
were harvested at mid-log phase (A600 ~ 1.5), washed, and resuspended in phosphate-
buffered saline (PBS; 10 mM Na2HPO4, 1.5 mM KH2PO4, 3.0 mM KCl, 150 mM NaCl, pH 
7.4) at 20-fold concentration. One ml of this cell suspension was warmed to room temperature 
and then supplemented with MTSEA-biotin (20 mM in dimethyl sulfoxide) to a final 
concentration of 0.1 mM. The reaction was stopped after 2 min by the addition of ice-cold 
citrate buffer to a final concentration of 50 mM (0.25M Citric Acid/KH2PO4, pH 4.0) and was 
incubated on ice for an additional 5 min. The low pH has previously been shown to prevent 
disulfide exchange reactions that might complicate the analysis (27). All subsequent steps were 
performed at 4°C unless otherwise indicated. MTSEA-biotin-treated cells were pelleted, 
resuspended in PBS, and lysed by vortexing with glass beads. Following a low speed spin (700 
X g, 5 min) to remove cell wall debris, unbroken cells, and glass beads, the resulting 
supernatant was centrifuged at high speed (15,000 X g, 30 min) to pellet membranes. The 
pellet was resuspended in PBS, and protein concentration was determined using the 
BioRad (BioRad, Hercules, CA) protein assay. Membranes were solubilized in RIPA buffer 
(0.1% SDS, 1% Triton  X-100, 0.5% deoxycholic acid, 1 mM  EDTA in 1X PBS, pH 7.4) 
for 1 h at room temperature with end-over-end mixing. The solubilized, biotinylated proteins 
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were collected on UltraLink Immobilized Streptavidin Plus beads (Thermo 
Scientific,  Rockford, IL) by incubation overnight at 4°C with end-over-end mixing. The 
beads were washed four times with ice-cold RIPA buffer, once with 2% SDS in PBS (room 
temperature), followed by a final wash with ice-cold RIPA buffer. During the washes the 
beads were resuspended and then allowed to settle by gravity for 20 min prior to removal of 
the supernatant. Bound proteins were extracted from the beads using SDS sample buffer 
(10% glycerol, 5% 2-mercaptoethanol, 1% SDS, 0.03% bromophenol blue, 62.5 mM Tris, pH 
6.8, 55°C, 5 min) and used for immunoblot analysis. Solubilized proteins were resolved by 
SDS-PAGE and immunoblotted using anti-FLAG™ M2 antibody as described under 
“immunoblots” in Methods. To verify Ste2p expression levels, an aliquot of total membrane 
proteins was solubilized in SDS sample buffer, fractionated by SDS-PAGE (5-10 µg/lane), and 
immuno-blotted in parallel with the biotinylated proteins extracted from the beads.   
 
Disulfide Cross-Linking with Cu-Phenanthroline: One hundred µg of membrane protein 
preparation was treated with a fresh preparation (pH 7.4) of Cu(II)-1,10-phenanthroline (Cu-P; 
final concentration, 2.5 μM CuSO4 and 7.5 μM phenanthroline). The reaction was carried out at 
room temperature for 20 min, terminated with 50 mM EDTA, and kept on ice for 20 min 
followed by adding SDS  sample buffer without 2-mercaptoethanol. In experiments designed to 
prevent disulfide bond formation, the membranes were treated with 5 mM NEM (N-
ethylmaleimide) for 20 min prior to incubation with Cu-P reagent. Alpha-factor or antagonist 
(desW
1
,desH
2
-α-factor) (10 µM final concentration) were added to the membrane preparation 
and incubation was allowed to proceed for 30 min prior to Cu-P treatment in experiments 
performed to examine the influence of ligand on dimerization.  
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Results 
 
Expression and Biological Activities of Single Cys and Cys-less Receptors 
We targeted residues G20 to G33 in the N-terminus of Ste2p, which comprised the 
predicted -strand (T23 to Y30) (28, 29) and an additional three residues on both the N- and C-
termini of the strand, for determining the solvent accessibility. To eliminate any non-specific 
reactivity with MTSEA-biotin in SCAM experiments (reported below), we used the Cys-less 
receptor that had been used previously for SCAM studies in our lab and those of others. In this 
receptor, the two native cysteine residues at C59 and C252 were replaced with serine resulting in 
a fully active receptor (30). Individual residues in the region of interest were replaced one at a 
time with cysteine to generate a total of 14 Cys mutants of Ste2p. Before embarking on SCAM, 
expression level and biological activities of each mutant receptor were measured.   
For determination of total receptor expression levels, membranes from yeast cells harboring a 
plasmid with each single Cys mutant receptor tagged with a FLAG- epitope were prepared, run 
on SDS-PAGE under reducing conditions, and immunoblotted using the FLAG™ antibody. Two 
additional single-Cys mutants (T199C and Y266C) were also studied as they served as controls 
in SCAM experiments reported below. Multiple repeats of immunoblot experiments yielded 
similar results and the standard deviation for each expression is indicated for each receptor 
(Table 2.1). Representative blots are shown in figure 2.1. Relative total expression level of the 
mutant receptors (monomers and dimers were both included in the calculated total expression; 
dimer formation is examined in greater detail below) was compared to the Cys-less receptor and 
normalized to the constitutively-expressed membrane protein Pma1p which was used as a 
loading control (Table 2.1). Expression levels of different mutants varied from ~4 fold lower 
(S22C) to ~1.6 fold higher (G31C) than the Cys-less Ste2p. Because SCAM experiments were 
59 
 
carried out in whole cells using a membrane impermeable reagent, surface expression of the 
receptors will directly affect the relative solvent accessibility of the mutants as reported below. 
Therefore, surface expression of the mutants was measured by saturation binding assays using 
tritiated [
3H]α-factor in whole cells. Since the relative Bmax value from saturation binding 
experiments represents the relative surface expression of a receptor, the Bmax values of the 
mutants were compared to that of the Cys-less receptors. As shown in Table 2.1, mutant surface 
expressions varied from ~5 fold lower (Y26C) to ~1.8 fold higher (T23C) as compared to the 
Cys-less Ste2p. When experimental error was taken into account 9 of the 14 Cys mutants showed 
a good correlation between the relative total expression and surface expression. Most 
significantly, correlation was quite good for the poorly expressed (G20C, S22C and Y26C) 
mutants. Three of the mutants (Q21C, T27C and N32C) showed a low surface expression 
compared to total expression and two (T23C and Y30C) showed a higher relative surface 
expression compared to total expression.  
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Table 2.1. Relative expression levels of Ste2p  
Receptor 
Relative Total 
Expression 
Level
a
 
Relative Surface 
Expression Level
b
 
Cys-less 1.00 ± 0.06 1.00 ± 0.01 
T199C 0.81 ± 0.10 1.25 ± 0.36 
Y266C 0.72 ± 0.13 1.14 ± 0.15 
G20C 0.49 ± 0.06 0.43 ± 0.13 
Q21C 1.06 ± 0.02 0.69 ± 0.05 
S22C 0.25 ± 0.06 0.20 ± 0.07 
T23C 1.13 ± 0.17 1.85 ± 0.05 
I24C 0.64 ± 0.20 0.75 ± 0.37 
N25C 1.09 ± 0.33 0.87 ± 0.36 
Y26C 0.26 ± 0.07 0.19 ± 0.04 
T27C 1.35 ± 0.21 0.78 ± 0.05 
S28C 0.63 ± 0.09 0.57 ± 0.21 
I29C 1.33 ± 0.08 1.57 ± 0.24 
Y30C 0.95 ± 0.14 1.51 ± 0.04 
G31C 1.56 ± 0.27 1.26 ± 0.07 
N32C 1.30 ± 0.13 0.76 ± 0.08 
G33C 1.06 ± 0.05 0.84 ± 0.05 
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a
Relative expression level of the Cys mutants of Ste2p. Ste2p band intensity was quantitated by 
Quantity One software (BioRad) and normalized to the Pma1p band intensity (amount of light 
emitted from the chemiluminecent signal as read by Quantity One) (for protein loading on the 
gel) and the Cys-less receptor. Expression level of each receptor on the same PAGE immunoblot 
was calculated as  
{
                               
                                  
}  {
                                 
                             
} 
 
b
Relative surface expression Cys mutants of Ste2p. Surface expression was determined by 
saturation binding assay using tritiated [
3H] α-factor with whole cells. The surface expression of 
receptors was determined from the Bmax values obtained from saturation binding assays using 
tritiated [
3H] α-factor with whole cells and the relative surface expression was expressed as 
                       
                                   
. 
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Figure 2.1. Ste2p expression levels. Total membranes prepared from cells expressing single 
Cys mutants of Ste2p (G20C to G33C, T199C, and Y266C) and the Cys-less receptor were 
run on separate gels shown in the three panels. Five µg of total membrane preparations 
from each mutant was immunoblotted using antibody against the C-terminal FLAG™ 
epitope tag. Molecular mass markers (kDa) are indicated on the left-hand side. M and D 
indicate the monomeric and dimeric forms of Ste2p, respectively. The same blot was 
stripped and then re-probed with anti-Pma1p antibody as a loading control.  
 
 
The biological activities of each mutant were measured by growth arrest, reporter gene 
activity, and binding assays and were normalized to those of the Cys-less receptor (Table 2.2). 
Pheromone-induced growth arrest activity of all the mutants was similar to that of the Cys-less 
receptor (between 85% and 103% of Cys-less receptor). One receptor, Y26C, was reported in a 
previous study to fail to trigger growth arrest (29). We believe the discrepancy between our study 
and that of Shi et al. (29) is due to differences in the strain background used. Signaling activity 
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as measured by the pheromone-induced FUS1-lacZ reporter gene activation assay was between 
57% (Y30C) and 127% (I24C) of the Cys-less receptor. Although expression of two receptors 
[S22C (25%) and Y26C (26%)] was lower than 50%, these mutants exhibited effective growth 
arrest and β-galactosidase activities suggesting that even the low expression of Ste2p was 
sufficient to elicit a strong biological response to pheromone. Previous studies also indicated that 
low levels of Ste2p were sufficient to manifest full biological responses (31-34). Finally, the 
alpha-factor binding affinity of each mutant was measured by saturation binding assays using 
whole cells. The binding affinity varied from ~50% (I29C) lower to ~50% (G33C) higher in 
comparison to that of the Cys-less receptor (Table 2.2). From the results of the above 
experiments, we conclude that all the single Cys mutants of Ste2p exhibited effective signaling 
and strong binding, and therefore Cys substitution did not cause any global change in the 
receptor conformation.  
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Table 2.2. Biological activities of Cys-less and single Cys mutants of Ste2p 
  
Receptor 
 
Growth Arrest Activity (%)
a 
 
β-galactosidase Activity (%)b 
 
        
Relative
 
Kd
c 
 
Cys-less 
100 ± 0.3 
 
100 ± 2.0 
 
1.00 ± 0.21 
 
T199C 
93± 7.0 
 
96± 5.0 
 
0.99 ± 0.20 
 
G20C 
89 ± 0.7 
 
71 ± 2.1 
 
1.15 ± 0.50 
 
Q21C 
97 ± 3.0 
 
125 ± 4.4 
 
0.71 ± 0.06 
 
S22C 
87 ± 8.1 
 
89 ± 4.4 
 
1.38 ± 0.79 
 
T23C 
97 ± 3.7 
 
113 ± 2.7 
 
1.44 ± 0.05 
 
I24C 
101 ± 3.5 
 
127 ± 6.2 
 
0.78 ± 0.39 
 
N25C 
89 ± 3.5 
 
108 ± 3.8 
 
0.75 ± 0.49 
 
Y26C 
85 ± 7.5 
 
113 ± 8.3 
 
1.09 ± 0.23 
 
T27C 
98 ± 8.0 
 
65 ± 8.2 
 
1.06 ± 0.08 
 
S28C 
103 ± 1.3 
 
58 ± 2.9 
 
0.65 ± 0.28 
 
I29C 
100 ± 2.3 
 
96 ± 3.6 
 
1.52 ± 0.20 
 
Y30C 
97 ± 3.5 
 
57 ± 4.6 
 
1.13 ± 0.30 
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Table 2.2 Continued  
Receptor 
 
Growth Arrest 
Activity (%)
a 
 
β-galactosidase 
Activity (%)
b 
 
        
Relative
 
Kd
c 
 
G31C 
101 ± 3.5 
 
71 ± 2.1 
 
1.49 ± 0.21 
 
N32C 
99 ± 1.3 
 
117 ± 2.4 
 
0.88 ± 0.15 
 
G33C 
100 ± 4.0 
 
61 ± 1.2 
 
0.53 ± 0.13 
 
 
 
a
Relative growth arrest activity (halo size ±standard deviation) was compared to that of the Cys-
less receptor at 0.5 μg of α-factor applied to a disk (the halo size of Cys-less was 23mm). 
bRelative β-galactosidase activity (±standard deviation) was compared with  that of Cys-less at 1 
μM α-factor. 
 
c
The Kd values (±standard deviation) are presented relative to those of the Cys-less receptor. 
The Kd was determined by saturation binding of radioactive α-factor according to the protocol 
described in experimental procedures. (Kd of Cys-less receptor was 10.8 nM). 
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Accessibility of N-terminal Cys residues  
The substituted cysteine accessibility method (SCAM) has proven to be an important means to 
determine the accessibility of residues as well as to gain knowledge about the secondary 
structure of transmembrane proteins. SCAM was performed in order to uncover the solvent 
accessibility of a portion of the N-terminus previously predicted to have secondary structure. For 
SCAM we used MTSEA-biotin, a thiol-specific, membrane-impermeable reagent. To ensure that 
the topology of the receptor was not perturbed by membrane preparation, whole cells were used 
instead of isolated membranes as in previous SCAM experiments in our laboratory which probed 
the first extracellular domain of Ste2p (14). The receptors T199C and Y266C were used as 
accessibility controls as they were shown to be fully accessible (T199C) and inaccessible 
(Y266C) to MTSEA-Biotin in previous studies (14, 35). Representative examples of 
immunoblots are shown in Figure 2.2. As shown in all panels, no detectable labeling was 
observed in the Cys-less and Y266C receptors but strong labeling was observed in T199C as 
had been reported previously. However, substantial variation in the labeling of the mutants 
was observed. Since cell surface expression of each mutant was different, the labeling of each 
mutant was normalized to its cell surface expression to determine accessibility. This was done to 
ensure that the solvent accessibility was not affected by the differential surface expression. 
Finally, accessibility of each mutant was normalized to that of T199C, which was assigned as the 
positive control for accessibility (100% labeling by MTSEA-biotin) (Table 2.3). 
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Figure 2.2. MTSEA labeling of the N-terminal residues of Ste2p. Ste2p Cys mutants at 
positions G20-G33 were labeled with MTSEA as described under Methods. T199C was 
used as a positive control, and Y266C and Cys-less receptors were used as negative 
controls. Molecular mass markers (kDa) are indicated on the left-hand side of the Fig. The 
bottom panel shows overexposed immunoblots of the top panels.  
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Table 2.3. Relative MTSEA-biotin labeling of Cys-scanned mutants of Ste2p 
Receptor Labeling
a
 
T199C 1.00 ± 0.15 
Y266C 0 
Cys-less 0 
G20C 0.09 ± 0.06 
Q21C 2.19 ± 0.05 
S22C 0 
T23C 0.32 ± 0.02 
I24C 0 
N25C 0.19 ± 0.04 
Y26C 0 
T27C 1.08 ± 0.02 
S28C 0 
I29C 2.00 ± 0.20 
Y30C 0.71 ± 0.02 
G31C 1.30 ± 0.03 
N32C 0.61 ± 0.04 
G33C 1.19 ± 0.06 
 
a
MTSEA-biotin labeling was adjusted to the surface expression of each mutant and normalized 
to the labeling of T199C as calculated as {(Band intensity of mutant/Bamx of mutant)×Bmax of 
T199C/Band intensity of T199C)}.  
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Examination of normalized accessibilities revealed that the residues in the target region 
are not equally solvent accessible despite the fact that the N-terminus of Ste2p is extracellular; 
residues in this region are expected to be equally solvent accessible. We found that four residues 
(S22C, I24C, Y26C and S28C) were not detectably labeled (even when the gels were 
overexposed, Figure 2.2 bottom). G20C, T23C and N25C were poorly labeled (<40%) and all of 
the other residues in this targeted region (Q21C, T27C, I29C, Y30, G31, N32, and G33) were 
labeled to 60% or more of the positive control. The amount of accessibility varied from ~5-fold 
less (N25C) to ~2-fold higher (Q21C and I29C) as compared to T199C (Table 2.3). Many 
mutants exhibited a lack of correlation between the surface expression and the solvent 
accessibility. For example, residues I24C and N32C have similar surface expression (75% and 
76%, respectively) as compared to the Cys-less, receptor (Table 2.1) but their accessibility is 
entirely different, i.e., N32C is highly accessible but I24C is completely inaccessible. 
The periodicity of accessibility from S22 to S28 in the N-terminus with residues S22, I24, 
Y26, and S28 showing no apparent accessibility and residues Q21, T23, N25, T27, and I29 
demonstrating accessibility would be consistent with that region of the N-terminus forming a -
strand structure as predicted in previous studies (28, 29) with one face of the -strand being 
shielded from solvent. One explanation for the solvent inaccessibility would be involvement of 
that portion of the N-terminus in a dimer interface. Previous studies have shown that deletion of 
the first 45 residues of the N-terminus decreased dimerization of Ste2p (36). Thus we explored 
the involvement of these -strand residues in Ste2p dimerization. 
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Involvement of specific N-terminal residues in dimer formation  
Cells expressing each of the different Cys mutants were grown and membranes were prepared. 
The samples were analyzed by SDS-PAGE in non-reducing conditions and probed with anti-
FLAG™ antibody. A small dimer band at ~110 kD was observed with the Cys-less Ste2p and all 
of the Ste2p Cys mutants under non-reducing (Figure 2.3A) and reducing conditions (Figure 
2.1). This “SDS-resistant” band has been observed consistently in studies of Ste2p (29, 33, 37, 
38). Under the non-reducing conditions (Figure 2.3A) there was an increase in the 
dimer/monomer for many of the mutants. For example in Fig. 1 under reducing conditions I24C 
is mostly in the monomeric form whereas in non-reducing conditions (Figure 2.3A) it is mostly 
dimeric. We attribute the increased dimers to disulfide formation between the Cys-substituted 
residues in the N-terminus as evidenced by the reversal of dimer formation by NEM pretreatment 
(compare Figure 2.3B & Figure 2.3E) and by the lower dimer/monomer ratio under reducing 
conditions (Figure 2.1). Under non-reducing conditions and in the absence of a catalyst, whereas 
the majority species was monomeric in the Cys-less and the Q21C, T23C, N25C, T27C, I29C, 
G31C, N32C, and G33C receptors, the G20C, S22C, I24C, Y26C, S28C, and Y30C receptors 
were mostly in the dimer form (Figure 2.3A). In previous studies, we have shown that Cys cross-
linking of Ste2p transmembrane domains and intracellular residues was promoted by Cu-P 
(Cu(II)-1,10-phenanthroline) treatment. Cu-P treatment provides a more oxidative environment 
and has been used in many experiments to determine Cys-Cys disulfide formation in membrane 
proteins (39-43). With Cu-P treatment, many of the six Cys mutants (G20C, S22C, I24C, Y26C, 
S28C, and Y30C) that showed a high dimer formation under non-reducing conditions (Figure 
2.3A) exhibited an even higher dimer population (Figure 2.3B). In addition, in the presence of 
Cu-P three mutants (N25C, T27C, and I29C), which did not form a significant proportion of 
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dimer under non-reducing conditions, showed increased dimerization (compare Figure 2.3A and 
Figure 2.3B). Dimer formation in the other mutants (Q21C, T23C, G31C, N32C, and G33C) was 
not affected to a major extent by Cu-P treatment. To verify that the Cu-P stimulated increase in 
higher molecular weight band was due to disulfide bond formation, samples were treated with 
NEM (N-ethylmaleimide) prior to Cu-P addition. NEM alkylates the free −SH group of cysteine 
irreversibly, so that disulfide bond formation cannot occur after NEM treatment. Representative 
data for five mutants (N25C to I29C) are shown in Figure 2.3E. NEM pre-treatment was found to 
block Cu-P stimulated dimerization for mutants N25C, T27C, and I29C (compare Figure 2.3B 
and Figure 2.3E).  
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Figure 2.3. Dimer formation by the Ste2p N-terminal Cysteine mutants. Membrane 
proteins untreated (A), treated with Cu-P (B), incubated with α-factor followed by Cu-P 
(C), incubated with antagonist followed by Cu-P (D) or NEM added prior to Cu-P (E) were 
separated by SDS-PAGE, then immunoblotted and probed with anti-FLAG™ antibody. 
The upper band (~110 kDa) represents dimerized receptor (indicated by “D”) and the 
lower band (~55 kDa) represents monomer (indicated by “M”). 
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Effect of ligand binding on dimerization 
 It has been observed that ligand binding can induce a change in a GPCR dimer interface (44, 
45). To examine the effect of ligand on Cys-mediated dimerization, membranes were incubated 
with either α-factor (agonist) or [desW1desH2]α-factor (an antagonist)  prior to Cu-P treatment.  
Notable reduction was observed in dimer formation for the N25C, T27C, and I29C mutants in 
the presence of α-factor (compare Figure 2.3B to Figure 2.3C). In contrast, dimerization of 
receptors with Cys in the other residues of this region was not greatly affected by agonist 
binding. In addition, Cu-P stimulated dimerization was not affected significantly by antagonist 
treatment for the mutants analyzed (compare Figure 2.3B and Figure 2.3D).  
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Discussion 
 
Binding of ligand to its cognate GPCR induces conformational changes in the receptor 
which promote signal transduction across the membrane and activate a G-protein mediated signal 
transduction cascade (46, 47). Ste2p, the α-factor pheromone receptor, is a GPCR expressed in 
the yeast Saccharomyces cerevisiae and has been used extensively as a model for peptide-
responsive GPCRs (48-50). Although Ste2p does not share sequence similarity with mammalian 
GPCRs or even with Ste3p, the a-factor pheromone receptor of yeast, all GPCRs have the same 
overall membrane architecture and manifest functional similarities such as G-protein coupling. 
The extracellular N-termini of GPCRs are highly variable differing greatly in length and 
sequence. Even within subfamilies, the N-termini often show low sequence homology. However, 
recent studies have indicated that the N-terminal regions of GPCRs play important roles in 
receptor function. For example, the N-terminus of several GPCRs has been found to be involved 
in ligand binding (51-53), and receptor dimerization (36, 54), and cell surface targeting (55). 
For Ste2p, extensive structure and function studies have been conducted on the 
intracellular domains and transmembrane domains, while fewer studies have focused on the 
extracellular N-terminal region. In those studies where this portion of Ste2p was studied, the role 
of the N-terminus in glycosylation (56), dimerization (36) and mating (28, 29) was examined. 
The Ste2p N-terminus is 48 amino acids long, and residues N25 and N32 are sites of N-linked 
glycosylation (56). Nevertheless, removal of these glycosylation sites still resulted in a fully 
active receptor (56). Deletion of the N-terminal 45 residues yielded a receptor that was deficient 
in dimer formation (36), and deletion of the first 30 amino acids of the N-terminus of Ste2p 
resulted in a cell that could not mate and showed weak signaling after pheromone addition (28). 
In another study, 17 residues in the N-terminus (P15, P19, T23 to I36 and, N46) were 
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investigated by substituting with Cys and Ala. This study showed that none of the substitutions 
affected signaling, but mutation of residues P15, I24 and I29 greatly lowered the mating ability 
of the cells carrying these mutations (29). 
In this study we have explored the solvent accessibility and involvement in dimer 
formation of a portion of the N-terminus of Ste2p to gain insights into the structure and function 
of this domain of the receptor. SCAM has been used previously to study the lining of pores of 
channels and transport proteins (57-59) and the binding site of acetylcholine receptors (60). More 
recently, this method has been applied to study G protein-coupled receptors (14, 15, 27, 61-64).  
Previous studies had suggested that certain residues in the N-terminus of Ste2p were critical for 
pheromone induced mating but not for G1 arrest. Marsh and co-workers using S. cerevisiae/S. 
kluyveri chimeras concluded that residues 1-45 were not involved in pheromone binding 
specificity (65). Our binding studies on the Cys mutants of residues 20-33 of Ste2p would be 
consistent with this observation. Despite the minor influence of the Cys mutations on receptor 
signaling and pheromone binding here we report the first experimental evidence that all residues 
in the N-terminus are not equally accessible and that the part of the N-terminus of Ste2p that 
putatively contains a -strand participates in dimerization of Ste2p. Notably, we uncovered a 
change in the conformation of the N-terminus upon agonist binding as determined by differences 
in disulfide-mediated dimer formation in the active and inactive stages of Ste2p (Figure 2.3).  
Our accessibility analyses showed that there were striking variations in the solvent 
exposure of residues in the region of the N-terminus between residues S22 and S28. Residues 
S22C, I24C, Y26C, and S28C were completely inaccessible to a membrane-impermeable, 
hydrophilic, thiol-specific reagent MTSEA-biotin even though I24C and S28C receptors were 
expressed at the cell surface as well as, or nearly as well as residues (Q21C, T27C, N32C, and 
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G33C) whose Cys residues were accessible to MTSEA-biotin (Table 2.1 and Table 2.3). 
Residues adjacent to the inaccessible residues readily reacted with the reagent. The differential 
labeling of residues G20-S33 of the N-terminal residues is surprising since all these extracellular 
residues were expected to be readily solvent accessible. The alternating pattern of accessibility of 
consecutive engineered cysteines suggests an underlying structure of this region which is 
consistent with predicted -strand spanning from Thr 23 to Tyr 30 (28, 29).  
Based on the above SCAM analysis we hypothesized that the putative -strand in the N-
terminus of Ste2p may be involved in dimerization of Ste2p, as the N-terminus of Ste2p had 
been shown previously to be part of the Ste2p dimer interface (36). Indeed, our results show that 
the cysteine-substituted residues S22, I24, Y26 and S28, which were not solvent accessible as 
judged by disulfide crosslinking to a biotinylation reagent, were involved in dimer formation. On 
the other hand, residues (Q21C, T23C, N25C, T27C, I29C) which would be on the opposite face 
of the -strand and thereby accessible to biotinylation were not involved in dimer formation 
under non-reducing conditions. Dimerization of the S28C mutant was blocked by NEM pre-
treatment (Figure 2.3E) corroborating the fact that dimerization was mediated by disulfide cross-
linking of two nearby Cys residues. Disulfide bond formation suggests that the α-carbons of the 
two Cys residues are located close to each other, within 7Å as the maximum distance, in order to 
result in a disulfide bond (33, 66-68). Our modeling shows that disulfide formation between 
residues in the N-terminus the putative -strand region would require a parallel arrangement of 
two Ste2p molecules. In contrast to our results, previous studies indicated that residue I24C was 
accessible in a SCAM experiment (29). The different outcomes between our and the previous 
investigation may reflect differences in the assay conditions used. In our assay, labeling 
experiments were performed with MTSEA-biotin using intact cells, whereas Shi and co-workers 
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used isolated membranes and fluorescein-5-maleimide. We have observed that accessibility was 
found to differ in experiments performed on isolated membranes versus whole cells in a study of 
Ste2p EL1 residues (14). 
Our results also demonstrate that agonist-induced conformational changes occur in the N-
terminus of Ste2p as indicated by -factor induced changes in the Cu-P catalyzed oxidation of 
dimerization for the N25C, T27C, and I29C mutants (compare Figure 2.3B and Figure 2.3CC). 
However, treatment with antagonist, which binds but does not activate the receptor, did not 
prevent the Cu-P-mediated increase in dimerization (compare Figure 2.3B, Figure 2.3C and 
Figure 2.3D). We postulate that the conformation of the N-terminus changes in the active state of 
the receptor such that the distance between these residues is too great for Cu-P induced disulfide 
bond formation. In contrast, the residues involved in dimer formation in the non-reducing 
conditions (22, 24, 26, and 28) still form a dimer interface in the activated state of the receptor. 
For these interactions between receptor monomers to occur, the parallel -strands must have 
enough flexibility to allow formation of disulfide bonds with residues on both faces of the -
strands as observed with Cu-P in the absence of alpha-factor.  
  
78 
 
Conclusion 
 
In conclusion SCAM analysis and disulfide crosslinking clearly show that in a short 
segment of the N-terminus of Ste2p certain residues do not react with a soluble biotinylation 
reagent and appear to be involved in receptor dimerization. The accessibility pattern, in 
particular, is consistent with a stretch of -sheet-like structure involving residues G20-Y30. 
Based on oxidative disulfide crosslinking studies, the dimer interface of the receptor changes in 
response to pheromone indicating a change in conformation of the N-terminus of the receptor 
during receptor activation. These studies provide evidence that the N-terminus of Ste2p 
possesses a discrete structural domain that appears to participate in the signaling mechanism. 
Information on the extracellular surface of other GPCRs should be useful in designing agents 
that can modulate signaling and thereby influence cell physiology. The methods applied to Ste2p 
should be applicable, therefore, to mammalian G protein-coupled receptors.   
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Chapter 3  
The N-terminus of Saccharomyces cerevisiae G protein-coupled 
receptor Ste2p is involved in negative regulation 
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Abstract 
 
Yeast pheromone receptor Ste2p is a G protein-coupled receptor that initiates cellular responses 
to α-mating pheromone, a 13-residue peptide.  We have examined the role of the extracellular N-
terminus of this receptor in signal transduction. Sequential deletion of the N-terminal residues 
affected cell surface expression without affecting ligand-binding affinity suggesting that the N-
terminus is required for efficient cell surface targeting. Deletion of portions of the N-terminus 
was found to affect signaling activity as determined by quantitative FUS1-LacZ gene reporter 
induction assay. However, when the receptor surface expression levels of deletion mutants were 
taken into account, the signaling activity was found to increase. This provides evidence that the 
N-terminus of Ste2p is involved in the negative regulation of receptor signaling. 
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Introduction 
 
Signal transduction is a fundamental biological process that is essential to maintain 
cellular homeostasis and processes in all organisms. The cells’ membrane proteins at the cell 
surface communicate between the extracellular and intracellular environments of the cell and 
respond accordingly to maintain cellular function. G protein-coupled receptors (GPCRs) 
represent one of the largest families of plasma membrane receptors in eukaryotes. More than 800 
GPCRs are encoded in the human genomes (1,2). These receptors play central roles in human 
physiology and thus modifications in the signaling of these receptors are pertinent for many 
diseases or pathological conditions including cardiovascular and pulmonary diseases, pain 
perception, obesity, cancer, and neurological disorders. (3-5) 
GPCRs share a common structural organization with an extracellular N-terminus, seven 
transmembrane domains connected by extracellular and intracellular loops, and a cytoplasmic C-
terminus (6,7). Despite the diversity of their ligands and a lack of strong sequence similarity, the 
underlying mechanisms of signal transduction are similar as GPCRs couple the binding of 
ligands to the activation of specific heterotrimeric guanine nucleotide-binding proteins (G 
proteins) and/or non-G protein mediated signaling, leading to the modulation of downstream 
effector proteins and gene expression (8-10).  
The GPCR superfamily of receptors is divided into several subgroups on the basis of 
phylogenetic criteria, conserved residues within the transmembrane helices and according to the 
size and characteristics of the N-terminal domain of its members. Historically, the bulk of 
attention of GPCR studies have focused on the transmembrane helices.  However, a number of 
studies indicate that the N-terminus also plays an important role in receptor function (6,11,12). A 
conserved N-terminal cysteine network in class B secretin receptors stabilizes their structure, the 
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alteration of which impairs ligand interactions (13). Likewise, a diverse variety of N-terminal 
domain motifs in the N-terminal domain of class B adhesion receptors determine ligand 
specificity. The conserved N-terminal Venus flytrap domain in Class C glutamate receptors and 
N-terminal Wnt-binding domains in Frizzled/Smoothened receptors have been reported to 
regulate ligand binding and receptor activation (6,11,12,14). The N-terminal domain of protease-
activated receptors (PARs) and glycoprotein hormone receptors (GpHRs) plays an important role 
in their activation (15,16). Recently, the N-terminus of GPR56, an adhesion G protein-coupled 
receptor that plays a key role in cortical development, has been reported to constrain receptor 
activity (17).  Truncation of the N-terminus of several GPCRs including CB1 cannabinoid (18), 
α1D adrenergic (19) and GPR37 (20) has been shown to enhance cell surface expression.  
Here we investigate the function of the N-terminus of the α-factor pheromone receptor 
Ste2p of Saccharomyces cerevisiae, which has been studied as a model for peptide-responsive 
GPCRs (21,22). Although there has been considerable study of the extracellular and intracellular 
loops as well as the C-terminus and transmembrane domains of Ste2p, less is known about the 
role of the N-terminal domain in signaling. The N-terminus of Ste2p is ~48 amino acids long, 
and it harbors two glycosylation sites (N25 and N32) which were eliminated by mutation (N25A 
and N32A) without affecting receptor function (23). Other studies indicated that the N-terminus 
contributed to receptor dimerization(24,25), and three residues (Pro 15, Ile24, and Ile29) were 
found to be essential for mating but not for signaling as measured by growth arrest and reporter 
gene (FUS1) activation assays (26). Truncation of parts of the N-terminus implicated this domain 
in cellular fusion (mating) during late stages of conjugation of opposite mating types (26). We 
performed deletion mutagenesis on the N-terminus and analyzed the mutant receptors by protein 
expression, ligand binding, and signaling assays. The results showed that deletion of the N-
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terminus affected the surface expression levels of the receptor and results in enhanced signaling 
activities of the receptor, suggesting that the N-terminus is involved in negative regulation of 
signaling.  
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Methods 
 
Media, Reagents, Strains, and Plasmids: S. cerevisiae strain LM102 [MATa ste2 FUS1-
lacZ::URA3 bar1 ura3 leu2 his4 trp1 met1] (27) was used for growth arrest, FUS1-lacZ gene 
induction, mating and saturation binding assays, and the protease-deficient strain BJS21 [MATa, 
prc1-407 prb1-1122 pep4-3 leu2 trp1 ura3-52 ste2::Kan
R
 (8) was used for protein isolation to 
decrease receptor degradation during immunoblot analyses (28). S. cerevisiae strain DK102 
[MATa, Ste2::HIS3, bar1 ade2, trp1, ura3, his, leu2, lys2] (29) was used for expression of the 
receptor under the control of Cu-inducible promoter CUP1. The plasmid pBEC2 containing C-
terminal FLAG™ and His-tagged STE2 (30) was transformed by the method of Geitz (31). The 
construction of pCUP1-BEC2 for expression of the C-terminal FLAG
TM
-His-tagged STE2 under 
the CUP1 promoter was done by inserting CUP1 from plasmid pmCUPNMsGFPX (32)  as the 
promoter of STE2.  Yeast transformants were selected by growth on yeast minimal medium (33) 
lacking tryptophan and supplemented with casamino acids (10g/L, Research Products 
International Corp., Prospect, IL.) designated as MLT to maintain selection for the plasmid. The 
cells were cultured in MLT and grown to mid log phase at 30°C with shaking (200 rpm) for all 
assays. S. cerevisiae strain TBR1 [MATα FLO11 ura3 his2 leu2] (34) was used the opposite 
mating type (LM102 MATa) for mating assays. [Lys
7
 (7-nitrobenz-2-oxa-1,3-diazol-4-
yl),Nle
12]α-factor abbreviated as [K7(NBD),Nle12]α-factor was synthesized as previously 
described (35).  
 
Growth Arrest Assays: S. cerevisiae LM102 cells, expressing Cys-less Ste2p and single Cys 
mutants, were grown at 30°C overnight in MLT, harvested, washed three times with water, and 
resuspended at a final concentration of 5 × 10
6
cells/mL (36). Cells (1 mL) were combined with 
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3.5 mL of agar noble (1.1%) and poured as a top agar lawn onto a MLT medium agar plate. 
Filter disks (BD, Franklin Lakes, NJ) impregnated with α-factor (4, 2, 1, 0.5, 0.25 µg/disk) were 
placed on the top agar. The plates were incubated at 30°C for 24h and then observed for clear 
halos around the disks. The experiment was repeated at least three times, and reported values 
represent the mean of these tests. For determination of growth arrest at various receptor 
expression levels, DK102 cells expressing receptors under the control of CUP1 promoter were 
grown for 16 hrs at 30C in minimal media. Cells were mixed with various final concentrations of 
CuSO4 and poured onto agar plates with minimal media.  
 
FUS1-lacZ Gene Induction Assay: LM102 cells, expressing Cys-less Ste2p and single Cys 
mutants, were grown at 30 ºC in selective media, harvested, washed three times with fresh media 
and resuspended at a final concentration of 5 x 10
7
 cells/mL. Cells (500 µl) were combined with 
α-factor (final concentration of 1.0 μM; this concentration is expected to saturate all the receptors 
on the surface) and incubated at 30ºC for 90 min. The cells were transferred to a 96-well flat 
bottom plate (Corning Incorporated, Corning, NY) in triplicate, permeabilized with 0.5% Triton 
X-100 in 25 mM PIPES buffer (pH 7.2) and then β-galactosidase assays were carried out using 
fluorescein di-β-galactopyranoside (Molecular Probes, Inc., Eugene, OR) as a substrate as 
described previously (8,37). The reaction mixtures were incubated at 37°C for 60 min and 1.0 M 
Na2CO3 was added to stop the reaction. The fluorescence of the samples (excitation of 485 nm 
and emission of 530 nm) was determined using a 96-well plate reader Synergy2 (BioTek 
Instruments, Inc., Winooski, VT). The data were analyzed using Prism software (GraphPad 
Prism version 5.03 for Windows, GraphPad Software, San Diego CA). The experiments were 
repeated at least three times and reported values represent the mean of these tests. For FUS1-
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LacZ induction in DK102 cells expressing wild type Ste2p under the control of CUP1 promoter, 
cells were grown overnight in minimal media containing adenine, histidine, tryptophan and 
lysine in the presence of various concentrations of CuSO4 (0.1-200 µM) before incubation with 
α-factor. 
Whole cell radioligand binding experiments: Tritiated [
3H] α-factor (9.33 Ci/mmol) prepared as 
previously described previously (38) was used in saturation binding assays on whole cells. Cells 
(LM102) expressing wild type or mutant Ste2p were harvested, washed 3 times with YM1 (39), 
and adjusted to a final concentration of 3 × 10
7
cells/mL. Cells (600 µL) were combined with 150 
µL of ice-cold 5× binding medium (YM1 plus protease inhibitors [YM1i] (39) supplemented 
with [
3H]α-factor and incubated at room temperature for 30 min. The final concentration of 
[
3H]α-factor ranged from 0.5 × 10−10 to 1 × 10−6 M. Upon completion of the incubation interval, 
200 µL aliquots of the cell-pheromone mixture were collected in triplicate on glass fiber filter 
mats and washed for 5 seconds with phosphate buffered saline, pH 7.4 using the Standard Cell 
Harvester (Skatron Instruments, Sterling, VA). Retained radioactivity on the filter was counted 
by liquid scintillation spectroscopy. Cells lacking Ste2p were used as a nonspecific binding 
control for the assays. Binding assays were repeated a minimum of three times, and similar 
results were observed for each replicate. Specific binding for each mutant receptor was 
calculated by subtracting the nonspecific values (radioactivity obtained from cells lacking 
receptor) from those obtained for total binding. Specific binding data were analyzed by nonlinear 
regression analysis for single-site binding using GraphPad Prism 5.04 (GraphPad Software, San 
Diego, CA) to determine the Kd and Bmax values for each mutant receptor. 
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Immunoblots: BJS21 cells, expressing wild type or the N-terminal deletion mutants of Ste2p 
grown in MLT, were used to prepare total cell membranes isolated as previously described (39). 
Protein concentration was determined by the BioRad protein assay (BioRad, Hercules, CA)(30), 
and membranes were solubilized in sodium dodecyl sulfate (SDS) sample buffer (10% glycerol, 
5% 2-mercaptoethanol, 1% SDS, 0.03% bromophenol blue, 62.5 mM Tris, pH 6.8). Proteins 
were fractioned by SDS−PAGE (10% acrylamide with 5% stacking gel) along with pre-stained 
Precision Plus protein standards (BioRad) and transferred to an ImmobilonTMP membrane 
(Millipore Corp., Bedford, MA). The blot was probed with anti-FLAG™ M2 antibody 
(Sigma/Aldrich Chemical, St. Louis, MO), and bands were visualized with the West Pico 
chemiluminescent detection system (Pierce). The total intensity of all Ste2p bands in each 
lane was determined using a ChemiDoc XRS photodocumentation system with Quantity 
One one-dimensional analysis software (version 4.6.9, BioRad, Hercules, CA). Immunoblot 
experiments were repeated at least three times and yielded similar results. Constitutively-
expressed membrane protein Pma1p was used as a loading control as described previously (40) 
using Pma1p antibody (Thermo Scientific, Rockford, IL). 
 
Deglycosylation of Membrane Proteins: Total membrane proteins prepared as described above 
were resuspended in sodium phosphate (50 mM, pH 7.5), supplemented with 500 units of 
glycerol-free PNGase F (New England Biolabs, Inc., Beverly, MA), and incubated at 37 °C for 2 
h. A negative control was run in parallel in which no enzyme was added prior to incubation at 37 
°C. Upon termination of the incubation interval, the membranes were pelleted by centrifugation 
(15,000 × g, 10 min), and the resulting pellet was dissolved in SDS sample buffer. The samples 
were used for FLAG immunoblot analysis as described above. 
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Quantitative Mating Assay: MATa cells expressing various Ste2p constructs and MATα cells 
expressing wild type receptor were grown overnight at 30°C, harvested by centrifugation, 
resuspended in fresh YEPD, and counted using a hemocytometer.   MATa cells (2×10
6
) were 
mixed with MATα cells (1×107) in a final volume of 100 µL, incubated at 30°C for 5 hours, 
washed three times with water and resuspended in a final volume of 1 ml water. Then 20 µL of 
the cell suspension was plated on minimal media lacking lysine and tryptophan and containing 
histidine and leucine and incubated for 2 days at 30°C.  Diploid colonies formed on the plates 
were counted and analyzed by using GraphPad Prism. This experiment was repeated at least 
three times and the mating efficiency was expressed as a percentage of diploid colonies formed 
by mating between the wild type MATa (LM102) and MATα (TBR1) strains. 
Flow Cytometry: S. cerevisiae strain DK102 expressing wild type Ste2p under the control of 
CUP1 promoter was grown for 16 hrs at 30C with various concentrations of CuSO4 and washed 
three times with 15 mM sodium acetate buffer (pH 4.6) containing sodium azide. Cells were re-
suspended in the same buffer to a final concentration of 1.5×10
6
 cells/ml. Cells (500 µl of the 
suspension) were incubated with 1 µM final concentration of a fluorescent α-factor analogue 
[K
7
(NBD),Nle
12]α-factor for 30 minutes at room temperature with end-over-end mixing. The 
cells were then washed three times with the same buffer containing sodium azide (10 mM) and 
200 µl of this cell suspension were added into a well of a 96-well plate and analyzed on a EMD 
Millipore (MA, USA) flow cytometer (Guava 6HT-2L) using excitation at 488 nm and emission 
at 525/30 nm (as specified by the Guava instrument). The samples were protected from light 
during pre-incubations and flow cytometry analysis. The mean fluorescence intensity obtained at 
various concentrations of CuSO4 was used to calculate relative cell surface expression. The mean 
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fluorescence data obtained from the Guava were analyzed by GraphPad Prism using non-linear 
regression analysis. 
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Results 
  
The mutant receptors are expressed but differentially glycosylated:  
To gain insight into the role of the N-terminus of the yeast α-factor receptor Ste2p in receptor 
function, we set out to identify specific regions in the N-terminus that influence receptor function 
(See Figure 3.1 for Ste2p snake diagram). For this purpose, we carried out deletion mutagenesis 
of the region between residues S2 to Y30 generating five mutants [Ste2pΔ2-10, Ste2pΔ11-20, 
Ste2pΔ21-30, Ste2pΔ2-20 and Ste2pΔ2-30 (Figure 3.2)] on the backbone of the full-length, Cys-
less receptor (Ste2p-C52S and C259S) with a His and FLAG tag extending from the C-terminus 
of Ste2p that we refer to herein as the wild type (Figure 3.1). Previous studies have established 
that this “wild-type” receptor was equivalent in expression and activity to the naturally occurring 
wild-type Ste2p (25,30,41). All mutants as well as the wild type receptor were expressed from a 
high copy yeast expression vector under the control of the constitutive GPD promoter (8,30).  
To test the mutant receptor expression, total membranes were prepared from yeast 
carrying each of the mutant constructs and the wild type control, the membrane proteins were 
solubilized and run on SDS-PAGE, immunoblotted, and probed with FLAG™ antibody (Figure 
3.3). As a loading control for immunoblot experiments, the same immunoblots were washed and 
re-probed with antibody against the constitutively expressed membrane protein Pma1p.  The 
experiment was repeated at least three times with similar results obtained in each experiment.  
Wild type Ste2p (Lane 2) appeared as a set of three major bands between 50 and 55 kDa, plus 
small amounts of higher molecular weight dimers (~100 kD) and oligomers, as observed in many 
previous studies, for example (30,42,43). Based on the primary amino acid sequence of the 
FLAG- and His-tagged receptor construct used in this study, the predicted molecular mass is 
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50.8 kDa (30). Glycosylation of the protein has been shown to result in the disparity of molecular 
weights of the Ste2p monomer (23,30,44,45).  
 
 
Figure 3.1. Diagram of Ste2p. The transmembrane domains are shown between the two 
parallel lines indicating the leaflets of the lipid bilayer. The intracellular and extracellular 
boundaries for the transmembrane domains are based on information obtained by SCAM 
analysis as reported previously (46). The receptor residues are numbered from the N 
terminus (residue 1) to the C terminus (residue 458) and include the inserted FLAG and 
His epitope tags (residues 432– 439 and 450 – 455, respectively), and spacer residues 
between the FLAG and His tags in the C-terminal portion. The two endogenous Cys 
residues mutated to Ser to generate the Cys-less Ste2p background are indicated by cross-
hatching in TM1 and TM6. 
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Figure 3.2. Schematic representation of the Ste2p mutants analyzed in this study. Each 
mutant is designated by the residue numbers deleted from the N-terminus and shown by 
the Δ symbol in the Fig. The upper line depicts the amino acid sequence for the N-terminal 
domain (box with amino acid sequence) and the seven transmembrane domains along with 
the C-terminal domain is indicated in black shades, not to scale. The potential glycosylation 
sites (N25 and N32) are indicated by the symbol Ψ. For each deletion mutation, the 
remaining Ste2p sequence is indicated (box with letters). The deleted sequence is indicated 
by empty box 
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Figure 3.3. Ste2p total expression levels. Proteins were solubilized from total membranes (5 
µg) prepared from cells expressing various N-terminal deletion mutants (Ste2pΔ2-10, 
Ste2pΔ2-20, Ste2pΔ2-30, Ste2pΔ11-20, Ste2pΔ21-30) and the wild type receptor and run on 
a SDS-PAGE gel and immunoblotted using antibody against the C-terminal FLAG™ 
epitope tag. M and D indicate the monomeric and dimeric forms of Ste2p, respectively. 
Molecular mass markers (kDa) are indicated on the left-hand side. The same blot was 
stripped and then re-probed with anti-Pma1p antibody as a loading control. 
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The expression level of each mutant receptor in the total membrane preparation was 
determined from the FLAG-reactive bands in each lane (monomer, dimer, and higher molecular 
weight bands), the loading in each lane was normalized to the Pma1p control, and then the 
expression levels were compared to the wild type receptor, the wild type receptor expression 
level was considered 100%). The total membrane expression levels were found to range from 
54% (Ste2pΔ2-30) to 81% (Ste2pΔ11-20) of the wild type.  
In addition to the reduced levels of expression, the mutants Ste2pΔ2-20, Ste2pΔ2-30, 
Ste2pΔ11-20, and Ste2pΔ21-30 exhibited altered banding patterns as compared with the wild 
type (Figure 3.3; Figure 3.4 lanes designated by C). We postulated that the different banding 
patterns were due to differential glycosylation of the mutant receptors as the two glycosylation 
sites of the receptor (N25 and N32) are located either within or adjacent to the deletion sites. To 
test this assumption, membranes were prepared from the mutants as well as the wild type cells, 
treated with PNGase F at 37°C to deglycosylate the receptor, and the banding pattern was 
examined. The higher molecular weight forms (greater than 130Kda) of Ste2p are attributable to 
receptor aggregation as a result of the incubation of the sample at 37°C for 2 hours which are 
conditions necessary for the deglycosylation reaction [Figure 3.4, Lanes (-) and Lanes (+)]. The 
aggregation of the receptor is likely responsible for the significant reduction in the overall 
intensity of the Ste2p monomer band after the treatment (Compare lanes C and _ or + in Figure 
3.4). Such temperature-dependent aggregation has been observed previously by our lab (30). The 
results indicated that the variability in the number of bands was diminished after PNGaseF 
treatment with most receptors exhibiting a prominent single band and the aforementioned high 
MW aggregate near the top of the gel (except  Ste2pΔ2-30 which was not glycosylated) (Figure 
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3.4). The collapse of the multiple bands at 50-55 kDa into one major band at about 50 kDa after 
PNGaseF treatment has been reported previously (23,30).  
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Table 3.1. Total expression, surface expression and binding affinity of Ste2p N-terminal 
deletion mutants 
aRelative total expression level (±SEM) of the N-terminal deletion mutants of Ste2p. Ste2p band 
intensity was quantitated by Quantity One software (BioRad) and normalized to the Pma1p band 
intensity (for protein loading on the gel) and the Cys-less wild type receptor. Expression level of 
each receptor was calculated as  
{
                          
                                  
}  {
                                   
                               
}  
bRelative surface expression (±SEM) of N-terminal deletion mutants of Ste2p. Surface 
expression was determined by saturation binding assay using tritiated [
3H] α-factor with whole 
cells. The relative surface expression was expressed as 
                       
                                     
 
cThe Kd values (±SEM) are presented relative to those of the Cys-less wild type receptor. The Kd 
was determined by saturation binding of radioactive α-factor according to the protocol described 
in experimental procedures. (Kd of wild type receptor was 21.93 nM). 
 
Receptors Relative total expression 
levels
a
 
Relative Bmax
b
  Relative Kd
c
 
Wild type 1.00 ± 0.07 1.00 ± 0.08 1.00 ± 0.16 
Ste2pΔ2-10 0.79 ± 0.08 0.89 ± 0.07 1.33 ± 0.22 
Ste2pΔ2-20 0.62 ± 0.06 0.31 ± 0.02 1.18 ± 0.17 
Ste2pΔ11-20 0.81 ± 0.07 0.26 ± 0.03 0.93 ± 0.22 
Ste2pΔ21-30 0.56 ± 0.06 0.17 ± 0.03 1.48 ± 0.49 
Ste2pΔ2-30 0.54 ± 0.05 0.09 ± 0.01 1.00 ± 0.23 
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Figure 3.4. Deglycosylation of N-terminal deletion mutants of Ste2p. Total membrane 
proteins derived from cells expressing wild-type or deletion mutant receptors indicated 
were treated (+) with PNGase F as described under “Experimental Procedures” or 
incubated in parallel in the absence of enzyme (-) to control for degradation or aggregation 
which might occur as a result of exposure to elevated temperature. The proteins were then 
analyzed by immunoblot analysis using the anti-FLAG antibody. In control lanes (C) 
membrane proteins were solubilized directly into denaturing sample buffer immediately 
prior to SDS-PAGE and subsequent immunoblot analysis. Molecular mass markers (kDa) 
are indicated on the left-hand side of each panel. The prominent bands visible at ∼50 kDa 
corresponds to the monomeric forms of glycosylated Ste2p, whereas deglycosylated 
receptor (Ste2p, degly-M) appears as a band of reduced molecular weight. 
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The N-terminus is important for efficient surface expression but not required for ligand-
binding: 
The immunoblot analysis measured total receptor expression in the membrane fraction, 
but it did not provide information regarding receptor expression on the cell surface. 
Consequently, the surface expression of the mutants was determined by whole cell saturation 
binding assays using [
3H]α-factor as described previously (39,41,47). The Bmax values from the 
saturation binding curves (Figure 3.5) were used to calculate the number of receptors on the cell 
surface (47).The surface expression level of Ste2pΔ2-10 was approximately 90% of the wild 
type, but the surface expression levels of the other mutants were significantly lower (p= 0.05) 
and varied between 9% (Ste2pΔ2-30) and 31% (Ste2pΔ2-20) of the wild type (Table 3.1). These 
results indicate that receptors with N-terminal deletions are well expressed as judged by total 
expression levels but they exhibited reduced cell surface expression. The involvement of the N-
terminus in surface expression is consistent with our previous study (25) and those of others 
(48,49).  
The binding affinities of the receptors as determined by whole cell saturation binding 
assays (30,39) were not significantly different (p= 0.05) from the wild type receptor (Table 3.1). 
These results indicated that the N-terminus was not directly involved in ligand binding and did 
not influence the formation of the ligand-binding pocket which is consistent with the observation 
by Sen and Marsh that the N-terminus of Ste2p was not involved in determining ligand 
specificity (50). 
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Figure 3.5. Saturation binding of [
3H]α factor to various N-terminally deleted Ste2p. Whole 
cell saturation binding assay of [
3H]α-factor to wild type Ste2p and N-terminal deletion 
mutants were determined. From these saturation curves the binding affinities were 
determined by nonlinear regression analysis using GraphPad Prism. The data represent 
specific binding to cells as determined by subtracting the binding to an isogenic strain 
lacking the receptor from binding to cells containing wild type or mutant Ste2p. 
 
Deletion of portions of the N-terminal enhanced pheromone-induced signaling activity: 
 To investigate the role of the N-terminus in signaling activities, we examined the mutant 
receptors by pheromone-induced growth arrest and FUS1-LacZ induction assays as well as 
quantitative mating assays. The growth arrest assay measures the response of cells expressing 
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Ste2p to arrest growth at the G1 phase based on the size of halos surrounding disks impregnated 
with various amounts of pheromone applied to lawn of pheromone-responsive cells. This assay 
measures response over a 24 to 48 h time frame. The FUS1-LacZ induction assay measures an 
early response (1 to 2 h) of the yeast cells to pheromone as detected by induction of β-
galactosidase activity through a reporter gene construct consisting of a fusion between FUS1, a 
pheromone-responsive promoter, and the LacZ gene (51). Mating assays measure the ability of 
the cells to conjugate with cells of the opposite mating type producing diploid cells. The number 
of diploid colonies formed as a result of mating between the two mating types can be compared 
to that of the wild type indicating mating efficiency. The signaling responses of the mutants in 
each experiment were normalized to those of the wild type (Figures 3.6, 3.7, 3.8 and Table 3.2).  
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Figure 3.6.  (A) Growth arrest (halo) assays of wild type and deletion mutant receptors. 
Cells containing wild type Ste2p or cells with N-terminally truncated Ste2p were plated 
onto medium. Disks containing α-factor (4.0, 2.0, 1.0, 0.5, and 0.25 µg/disk, starting at the 
12 O’clock position on each plate and moving clockwise) were placed onto the lawn of cells. 
The plates were incubated for 48−72 h at 30°C: a) wild type, b) Ste2pΔ2-10, c) Ste2pΔ11-20 
d) Ste2pΔ21-30  e) Ste2pΔ2-20, f) Ste2pΔ2-30. (B) Halo size produced by the wild type and 
various mutants at 1.0 µg α-factor was compared. 
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In growth arrest assays, the halo diameter produced by the same amount of ligand was 
compared (Figure 3.6B & Table 3.2). The results showed that the growth arrest responses of the 
mutants were nearly the same as those of the wild type, with the exception of Ste2pΔ2-30 which 
had a 25% decrease in halo diameter compared to the wild type at 1.0 µg α-factor (Figure 3.6B). 
Although the number of receptors on the cell surface of the mutants was different (Table 3.1), 
the growth arrest activity of the mutants was similar with the exception of Ste2pΔ2-30. 
Therefore, the growth arrest response in the N-terminal deletion mutants was not proportional to 
the level of receptor expressed on the surface.  
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Figure 3.7. (A). Pheromone-induced FUS1-LacZ induction. Dose-response curves for α-
factor stimulated FUS1–lacZ induction of the N-terminal deletion mutants. Data are 
expressed as a percentage of the maximal response stimulated by the full length wild type 
receptor. (B). Maximal induction (%) is determined from the data on panel A with the 
highest concentration of α-factor (1 µM). Results represent average from three 
independent experiments performed in quadruplicate. One-way ANOVA followed by 
Dunnett’s post hoc test was used to determine statistical significance (n = 4; p < 0.05).  
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 In FUS1-LacZ induction assays (Table 3.2 and Figure 3.7A) all mutant receptors 
exhibited potencies (EC50 values) similar, not less than or greater than 30%, of that of wild type 
receptor. Maximal responses produced by the mutants reflect efficacy (intrinsic activity) of the 
receptors. In contrast, potency (EC50), the molar concentration of an agonist required to produce 
50% of the maximal response to the agonist, reflects a complex function of both efficacy and 
affinity. Therefore, increased maximal signaling by Ste2pΔ2-10 indicates that deletion of the 
residues 2-10 in the N-terminus enhances the intrinsic signaling activity of the receptor. Also 
constitutive signaling, as measured by gene reporter activity in the absence of added α-factor, 
was the same as wild type for each receptor (data not shown). In contrast, the maximal signaling 
activity or efficacy, (FUS1-LacZ expression obtained at 1×10
-6
 M α-factor) exhibited variation 
among the receptors with signaling between 28% (Ste2pΔ2-30) and 152% (Ste2pΔ2-10) of the 
wild type (Table 3.2 and Figure 3.7). Out of the five mutants tested, Ste2pΔ2-20, Ste2pΔ21-30, 
and Ste2pΔ2-30 exhibited a significant decrease in signaling (p<0.05), Ste2pΔ11-20 exhibited 
similar activity as the wild type and Ste2pΔ2-10 appeared to increase the signaling activity.  
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Figure 3.8. (A). Auxotrophic MATα strain (TBR1 was mated with MATa STE2Δ yeast 
strain (LM012) expressing wild type (a) Ste2pΔ2-10 (b), Ste2pΔ2-20 (c) Ste2pΔ21-30 (d), 
Ste2pΔ11-20 (e) and Ste2pΔ2-30 (f). (B). Mating efficiency of the strains were analyzed and 
compared to that of the wild type. Statistical significance was analyzed at p<0.001 by using 
GraphPad Prism. 
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The two mutants Ste2pΔ2-10 and Ste2pΔ11-20 exhibited enhanced mating efficiency 
(p<0.001) (Figure 3.8). Statistical analyses revealed that the mating efficiency of the Ste2pΔ2-
20, Ste2pΔ2-30, and Ste2pΔ21-30 was not significantly different from that of the wild type at 
p<0.001. 
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Table 3.2. Signaling activities of Ste2p mutants. 
Receptors Relative 
growth arrest 
activity
a
 
Relative 
maximal FUS1-
LacZ Induction
b
 
EC50(nM)
c
 Maximal FUS1-LacZ 
induction/Surface 
expression
d
 
Wild type 1.00 ± 0.05 1.00 ± 0.06 46 ±5 1.00 ± 0.06 
Ste2pΔ2-10 1.02 ± 0.04 1.52 ± 0.01 32 ± 4 1.7 ± 0.08 
Ste2pΔ2-20 0.96 ± 0.04 0.39 ± 0.03 56 ± 2 1.3± 0.07 
Ste2pΔ11-20 1.06 ± 0.05 0.94 ± 0.04 36 ± 3 3.6± 0.30 
Ste2pΔ21-30 0.95 ± 0.05 0.30 ± 0.01 44 ± 1 1.8 ± 0.18 
Ste2pΔ2-30 0.72 ± 0.04 0.28 ± 0.02 48 ± 1 3.1 ± 0.20 
 
a
Relative growth arrest activity (halo size ±SEM) was compared to that of the Cys-less wild type 
receptor at 1.0 μg of α-factor applied to a disk (the halo size of the Cys-less wild type was 
23mm). 
b
Relative maximal FUS1-LacZ induction (±SEM) of each mutant was calculated  with  respect to  
Cys–less wild type  receptor  when  induced  with  the  highest concentration  of α-factor  (1 
µM).  
c
Determined from FUS1–lacZ assays. EC50 (potency) reflects the concentration of α-factor 
required to cause half–maximal induction. 
d
Maximal FUS1-LacZ induction of each mutant was normalized to its surface expression level 
and compared to that of the Cys-less wild type. 
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We have shown that deletion of portions of the N-terminal tail of Ste2p decreased the 
surface expression level of mutant receptors without any significant change in their binding 
affinities (Table 3.1). Although surface expression of Ste2p has been found to affect signaling 
activity as determined by FUS1-LacZ reporter assay (Figure 3.7), the calculated signaling 
activities do not take into account the level of surface expression. Therefore, to compare the 
signaling activities of the mutants based on the cell surface expression the maximal FUS1-LacZ 
activation was normalized to the amount of receptor on the cell surface as determined by 
saturation binding experiments. Interestingly, although the apparent signaling activity of the 
mutants was weaker than that of the wild type, this normalization revealed that the maximum 
FUS1-LacZ response of the mutants was in fact stronger than the wild type (Figure 3.9). We 
observed that truncation of the N-terminus significantly enhanced the relative FUS1-LacZ 
response by 2- to 3-fold. Thus, receptors lacking portions of the N-terminus are actually more 
effective with respect to signaling than the wild type.  
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Figure 3.9. Normalized FUS1-LacZ activity of each receptor construct as compared the 
wild type. The maximal signaling activity of each construct was normalized to the number 
of receptors expressed on the cell surface. One way ANOVA was carried out at p<0.05 to 
determine statistical significance using GraphPad Prism 
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In order to further evaluate the relationship of signaling to surface expression of various 
Ste2ps, we ascertained the surface expression and signaling activity with the same wild type 
receptor expressed at various levels. The wild type Ste2p was expressed under the control of 
Copper-inducible promoter CUP1 from the URA3 based plasmid pCBEC2 (52). We performed 
growth arrest and FUS1-LacZ assays to determine if there was any correlation between the 
surface expression level and signaling activities. Relative surface expression levels at various 
concentrations of CuSO4 was determined using a fluorescent α-factor analogue 
[K
7
(NBD),Nle
12]α-factor (35,53) by flow cytometer. We were able to regulate the surface 
expression level of Ste2p in a dose-dependent manner such that incubation with increasing 
concentrations of CuSO4 led to increasing the amount of [K
7
(NBD),Nle
12]α-factor on the surface 
as measured by mean fluorescence intensity (Figure 3.10). As judged from Figure 3.10B, there 
was a large increase in the number of receptors at 50 M CuSO4.  
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Figure 3.10. Receptor expression level at the cell surface determined by flow Cytometry. (Wild type Ste2p expressed under the 
control of copper-inducible promoter at different concentrations of CuSO4. A) FACS histograms of cells expressing no 
receptors (top panels) and wild type (bottom panels) in the presence of saturating concentration of the ligand. The 
concentrations of CuSO4 (μM) were 0 (a), 5 (b), 10 (c), 20 (d), 50 (e) and 100 (f) B). The histograms represent the number of 
cells (Y-axis) plotted against the fluorescence intensity (X-axis). The mean fluorescence intensity obtained from the histograms 
(insert number, upper right hand corner of histograms) was analyzed using non-linear regression analysis in GraphPad 
Prism. 
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Growth arrest assay indicated that the halos were turbid with indistinct edges at lower 
receptor expression levels. However, at higher expression levels, the halos were less turbid with 
distinct edges (Figure 3.11A). The results indicated that halo size was similar at the various 
concentrations of CuSO4 used in the experiment. The result is consistent with previous studies in 
which it has been shown that halo size produced by cells with different receptor expression level 
was similar (54). In FUS1-LacZ induction assays increasing signal was observed as the 
concentration of CuSO4 increased (Figure 3.11B). 
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Figure 3.11. Signaling activities of the wild type receptor expressed at different levels. (A) 
Growth arrest assay at various concentrations of CuSO4 (μM): (a) 0 (No added CuSO4) (b) 
0.2, (c) 0.5, (d) 1.0, (e) 2.0, (f) 5.0, (g) 10.0, (h) 20.0, (i) 50.0, (j) 100. (B) FUS1-LacZ 
induction at different concentrations of CuSO4 (μM): 0 (no added CuSO4), 0.2, 0.5, 1.0, 2.0, 
5.0, 10, 20, 50 and 100. Data from FUS1-LacZ assay were analyzed by non-linear regression 
analysis using GraphPad Prism.    
 
Detection of increase in FUS1-LacZ activity (Figure 3.11B) was more sensitive to lower 
CuSO4 induction levels than was detection of surface expression of Ste2p (Figure 3.10A & B). 
These results supported our hypothesis that signaling activity judged by the gene induction assay 
is correlated to receptor expression levels, although this relationship is not clear at lower 
expression levels due to the inability of flow cytometry to detect receptor expression above the 
background level at CuSO4 levels below 20 µM. 
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Discussion 
 
The N-termini of several GPCRs have been reported to play roles in receptor function 
such as constraining receptor activation (17) or acting as a tethered ligand (55). The N-terminus 
of Ste2p was previously associated with dimerization (24,25,56), mating (26,57) and as a site for 
glycosylation (23). Consistent with previous studies (49,50), we found that the N-terminus was 
important for cell surface expression but not required for ligand binding. Our experiments on the 
N-terminus indicated that deletion of N-terminal regions resulted in enhanced signaling as 
analyzed by FUS1-LacZ assays when normalized to Ste2p surface expression.  
It is generally assumed that the signaling activity of Ste2p is independent of receptor 
expression level (45,58,59). This assumption was based on signaling activities determined by the 
growth arrest assay and direct measurement of surface receptor expression level determined by a 
binding assay (54). In addition, the Dumont group supported this conclusion based on their 
analysis of the FUS1-LacZ assay (43). However, interpretation of the Gehret et al. (43) 
experiments involving the signaling activity as determined by the FUS1-LacZ assay was 
complicated by the fact that only the total expression, not the surface expression of Ste2p, was 
evaluated for the two strains: Ste2p expressed from the normal chromosomal STE2 locus versus 
Ste2p expressed under repressed condition from the GAL1 promoter (absence of galactose and 
the presence of glucose). The interpretation is also complicated by the concerns that receptor 
expression level on the cell surface and the number of G protein subunits available to interact 
with the activated receptor can affect the signaling activity. It has been reported that the number 
of G proteins is approximately equal to the number of receptors in cells containing normal 
chromosomal copies of the genes encoding receptors and G protein subunits (60-62). Therefore, 
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if the available G proteins are saturated with the receptors expressed on the surface, increasing 
the expression level of Ste2p beyond the available of G proteins will not increase signaling.  
The FUS1-LacZ reporter gene assay has been used as a quantitative assay for 
measurement of pheromone-induced signaling through Ste2p and its mutants in numerous 
studies (27,47,51,63,64). Our analyses with wild type receptor expressed under the control of a 
copper-inducible promoter CUP1 demonstrated that signaling activity as measured by FUS1-
LacZ was dependent on the number of surface expressed receptors (Figure 3.10 & 3.11B). This 
observation is consistent with the idea that the signaling activity as determined by the FUS1-
LacZ assay is dependent on the surface expression level of Ste2p. However, the signaling activity 
as determined by growth arrest assay does not correlate to the level of expression at the levels of 
copper used in the experiments (Figure 3.11). The difference in the two measurements of 
signaling activities indicates that the long-term growth arrest assay is relatively less responsive to 
the amount of receptor expressed at the cell surface. The apparent differences in the results of the 
two assays may be a consequence of difference in the level of receptor expression in cells grown 
in suspension versus cells grown on agar or the time frame of the assays.  
Mutants that were found to exhibit the greatest reduction in cell surface expression 
demonstrated marked changes in the banding pattern for Ste2p on SDS-PAGE (Figures 3.3 and 
3.4). It is probable that the changes in the banding pattern were due to altered glycosylation of 
the mutants because of either deletion of, or proximity to, the mutation of the two Ste2p 
glycosylation sites at N25 and N32. Accordingly, deglycosylation of the receptors resulted in the 
collapse of several bands into a major band which is consistent with previous studies in our lab 
(30) and others (23). However, removal of the two glycosylation sites does not affect receptor 
activity or subcellular localization (23). Thus reduced surface expression cannot be attributed 
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simply to changes in the glycosylation pattern of the receptors. It has been reported previously 
that the charged residues in the N-terminus are important for proper orientation of the receptor in 
the membrane (49). It is reasonable that a combination of the modification in the glycosylation 
pattern and changes in the electrostatic properties of the N-terminus influence the localization of 
Ste2p and its orientation in the plasma membrane. 
Despite reduced surface expression and altered glycosylation, the mutant receptors were 
still functional, i.e., they exhibited similar ligand binding affinity and responded to ligand 
effectively in both growth arrest and gene induction assays. When the signaling activities of the 
mutant Ste2ps were normalized to the number of receptors that bound α-factor, the mutants 
actually exhibited a greater response than wild type. In fact the Ste2p11-20 and Ste2p2-30 
mutants are more than 3-fold more effective than the full-length receptor in the signaling 
efficacies as measured by the reporter gene assay. Nevertheless, the activity of the Ste2p2-20 
receptor was similar to wild type receptor showing that regulation by the N-terminus governing 
signaling response is complex and cannot be divided onto linear domains. Our control 
experiments with wild type receptor at various expression levels support the conclusion that 
maximal signaling activity as measured by gene reporter is dependent on receptor expression 
levels on the cell surface.  
For measurement of signaling activities, we used pheromone-induced growth arrest and 
FUS1-lacZ assays. The growth arrest activities of the mutants were found to be similar to the 
wild type with the exception of Ste2p∆2-30. The reduced signaling of Ste2p∆2-30 mutant may 
be attributed to inefficient targeting to the membrane (49). However, this mutant construct still 
binds the ligand efficiently and signals. This mutant was reported previously to exhibit weaker 
growth arrest activity with indistinct halo edges as compared to ours (57). As shown in our 
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control experiment with the wild type receptor, the fuzzy halo may result from poor expression 
level on the cell surface (Figure 10A). The difference in the signaling activity by growth arrest 
may also be attributed to the differences in strain background and promoter used in our study as 
compared to that of Shi, et al. (57). We expressed the receptor from a constitutively active GPD 
promoter while they used an inducible GAL1 promoter. Further examination of signaling 
activities using a more sensitive, quantitative and shorter term reporter gene activation assay 
(FUS1-LacZ) revealed that the signaling activity of the mutants was enhanced as compared to the 
wild type when receptor expression levels at the cell surface are taken into account to normalize 
signaling activities.  
The results from the gene induction assay (Figure 3.9) indicate that the N-terminus of 
Ste2p is involved in negative regulation of signaling activity by this GPCR. In fact, the N-
terminus of another GPCR, GPR56, has been reported to constrain receptor activity (17). The N-
terminus of GPR61, an orphan GPCR that is abundantly expressed in the brain, was also reported 
to be essential for constitutive activity (65). Thus the results from our analysis of the role of the 
N-terminus of Ste2p in its function, and those of others involving different mammalian GPCRs, 
indicate an increasing importance for the N-terminus in the biology of GPCRs. Although the N-
terminus may not be essential for GPCR signaling, its role in the regulation of signaling has been 
ignored to some extent in previous studies. The N-terminus may be required for fine tuning the 
signaling process and thus may be an important drug target for future drug design studies in 
which the GPCR function can be regulated more specifically.  
 
 In order for the N-terminus to be involved in negative regulation of Ste2p signal 
transduction, it is likely that the N-terminus interacts with receptor domains that are important 
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for signal transduction. A secondary structure analysis suggested that regions of the N-terminus, 
in particular residues 20-30, have a strong tendency to form β-sheet structures, (25,57). It is 
possible that removal of portions of the N-terminal domain lowers either intramolecular 
interactions within Ste2p or intermolecular contacts with other domains of the Ste2p dimer 
(24,25). The sum of these β-sheet-like contacts may help to maintain the receptor in its inactive 
conformation and their removal would thereby facilitate transition to an activated state upon 
ligand binding. We speculate that the interacting domain with the N-terminus is the extracellular 
loop one (EL1) as mutation of residues in this loop has been found to change the glycosylation 
patterns of the receptor and its ability to be activated, and a structure prediction also indicates a 
tendency to form sheet secondary structures (30,57). However, we do not exclude the possibility 
of interactions with other Ste2p domains. Overall, this study demonstrates that important 
information about receptor regulation can be obtained from the study of the N-terminus. 
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Chapter 4  
Formation of Ste2p dimers by a conserved tyrosine residue in the N-
terminus that has multiple contacts with the extracellular loop 1 
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Abstract 
Ste2p, a Saccharomyces cerevisiae G protein-coupled receptor (GPCR) that responds to the 13 
amino acid-peptide, α-factor pheromone, initiates the yeast mating pathway after ligand binding. 
This receptor has been used as a model to understand the molecular mechanism of signal 
transduction by GPCRs, which play essential roles in signal transduction in eukaryotes. Single 
and double cysteine mutants of Ste2p were analyzed by disulfide cross-linking to determine 
intramolecular and intermolecular interactions. A conserved tyrosine residue (Y26) in the 
extracellular N-terminus was found to be a part of a Ste2p dimer intermolecular interface. Y26-
mediated dimerization was hindered by mutations at V109 and T114, two residues in the 
extracellular loop 1 (ECL1), suggesting an interaction between Y26 and V109 or T114. The 
amount of Ste2p dimerization was affected by ligand binding suggesting a conformational 
change in the N-terminus of the receptor upon activation. In this study we identified a specific 
residue in the N-terminus that is involved in dimerization, found interactions between the N-
terminus and ECL1, and suggested that the N-terminus changes conformational upon receptor 
activation.  
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Introduction 
 
Transmission of extracellular signals across the plasma membrane by receptor-mediated 
signaling is one of the most fundamental biological processes. G protein-coupled receptors 
(GPCRs) are by far the largest and most versatile signaling molecules on the cell surface that are 
involved in communication between the extracellular and intracellular environment of a cell. 
These receptors serve as highly versatile membrane sensors responding to a broad range of 
signals, including photons, hormones, neurotransmitters, ions and lipids (1-3) and translate them 
into cellular response. These receptors play crucial roles in many physiological and 
pathophysiological processes (4). Not surprisingly, GPCRs are therapeutic targets for a major 
portion of currently used drugs (1,5-8). The pharmacological relevance of these receptors is 
firmly established by the fact that approximately 30% of the known drugs on the market are 
designed to target GPCRs (9).  
The structural hallmark of GPCRs is their seven transmembrane domains connected by 
alternating extracellular and intracellular loops. Ligand binding promotes a conformational 
change in the receptor that triggers the cellular response via intracellular transducers, the 
heterotrimeric (α, ß, γ subunits) guanine (G-) nucleotide binding proteins and/or ß-arrestin (10). 
The conformational changes involve the movement of transmembrane domains (11-16). 
However, concomitant changes are also expected to occur in other domains of the receptor 
including the loop regions and the N- as well the C-termini.  
Structurally, a GPCR can be divided into three parts: (i) the extracellular region 
consisting of the N-terminus and the three extracellular loops (ECL1-ECL3), (ii) the 
transmembrane domains (TM1-TM7), and (iii) the intracellular region consisting of three 
intracellular loops (ICL1-ICL3), an intracellular amphipathic helix (H8) that is part of the C-
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terminus close to TM7, and the remaining portion of the C-terminus. Although all GPCRs 
contain these three distinct regions, the majority of studies have focused on the transmembrane 
helices. However, a growing number of studies indicate that the N-terminus also plays an 
important role in receptor function (17-20). For example, studies with class B secretin GPCRs 
indicate that the N-terminus is the ligand binding domain for these receptors (21). It has been 
proposed that binding of the cognate ligand to the N-terminus induces a conformational change 
in the receptor’s N-terminus that enables a built-in agonist epitope to dock near the top of 
transmembrane domain 6 and this in turn triggers a conformational change in the heptahelical 
bundle, thereby initiating the downstream signaling (22). In class C glutamate receptors, the 
conserved N-terminal Venus flytrap module in the N-terminus has been reported to regulate 
ligand binding and receptor activation (17,19,20,23). The N-termini of protease-activated 
receptors (PARs) and glycoprotein hormone receptors (GpHRs) have also been associated with 
receptor activation (24,25). The N-terminus of adhesion G protein-coupled receptor GPR56 has 
been reported to constrain receptor activity (26). Truncation of the N-terminus of several GPCRs 
including CB1 cannabinoid (27), α1D adrenergic (28) and GPR37 (29) has been shown to 
enhance cell surface expression.  
The Saccharomyces cerevisiae pheromone receptor Ste2p is a GPCR activated upon 
binding α factor, a 13-residue peptide, triggering the activation of a cytoplasmic heterotrimeric G 
protein in MATa haploid cells (30). Ste2p has been used as a model for understanding structure-
function relationships of GPCRs using the power of yeast genetics and analysis of the yeast 
pheromone response pathway. Although Ste2p lacks strong sequence similarity to mammalian 
GPCRs, some mammalian GPCRs have been expressed in yeast and are capable of activating the 
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yeast mating pathway (31,32). Ste2p also exhibits signaling when expressed in mammalian cells 
(33).  
The N-terminus of Ste2p is ~50 amino acids long and contains two glycosylation sites, 
neither of which are essential for receptor function (34). The N-terminus was also reported to be 
involved in forming a domain for Ste2p dimerization (35,36). Previous studies of the first 
extracellular loop using the substituted cysteine accessibility method (SCAM) reported that 
several residues (L102C, N105C, S108C, Y111C and T114C) in this loop were inaccessible to 
the sulfhydryl reagent (MTSEA-biotin) used to assess accessibility (37). It was also reported that 
mutation of these residues to cysteine affected the glycosylation pattern of the receptor. Because 
two glycosylation sites of the receptor are located in the N-terminus at N25 and N32 (34) and the 
mutations in the ECL1 affected the glycosylation pattern, we hypothesize that the N-terminus 
interacts with ECL1. More recently, several residues in the N-terminus including Y26C, were 
also found to be inaccessible to MTSEA-biotin and the Y26C mutant also exhibited markedly 
increased dimerization (35). This residue is in the consensus sequence of N-glycosylation N-X-
S/T (where X is any amino acid except Pro). The tyrosine in this position is conserved among the 
α-factor receptors in several fungal species (Figure 4.1). This observation stimulated this 
investigation into whether ECL1 interacts with N-terminus.  
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Materials and Methods  
 
Media, Reagents, Strains, and Plasmids: The Saccharomyces cerevisiae strain LM102 [MATa 
ste2 FUS1-lacZ::URA3 bar1 ura3 leu2 his4 trp1 met1] (38) was used for growth arrest, FUS1-
lacZ gene induction and saturation binding assays, and the protease-deficient strain BJS21 
[MATa, prc1-407 prb1-1122 pep4-3 leu2 trp1 ura3-52 ste2::Kan
R
 (39) was used for protein 
isolation, immunoblot analyses, and disulfide cross-linking studies in order to lower receptor 
degradation during analysis. To facilitate disulfide cross-linking, plasmid pBEC2-FXa was 
constructed from plasmid pBEC2 containing a Cys-less Ste2p using primers to introduce tandem 
Factor Xa protease cleavage sites between residues T78 and P79 in ICL1 (37). The plasmid 
pBEC2-FXa containing C-terminal FLAG™ and His-tagged STE2 with a tandem Factor Xa 
cleavage site was transformed by the method of Geitz (40). Transformants were selected by 
growth on yeast media (41) lacking tryptophan (designated as MLT) to maintain selection for the 
plasmid. The cells were cultured in MLT (2% glucose, 1% casamino acids (Research Products 
International Corp., IL, USA), 0.17% yeast nitrogen base without ammonium sulfate (Research 
Products International Corp., IL, USA), 0.5% ammonium sulfate (Research Products 
International Corp., IL, USA), amino acid dropout mix containing (arginine 0.026 g/L, 
asparagine 0.058 g/L, Aspartic acid 0.14 g/L, glutamic acid 0.14 g/L, histidine 0.028 g/L, 
isoleucine 0.058 g/L, leucine 0.083 g/L, lysine 0.042 g/L, methionine 0.028 g/L, phenylalanine 
0.69 g/L, serine 0.52 g/L, threonine 0.28 g/L, tyrosine 0.042 g/L, valine 0.21 g/L, adenine sulfate 
0.058 g/L, uracil 0.028 g/L)  and grown to mid log phase at 30°C with shaking (200 rpm) for all 
assays. 
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Growth Arrest Assays 
S. cerevisiae strain LM102 expressing Cys-less Ste2p (ICL1-Xa2) and Cys mutants were grown 
at 30°C overnight in MLT, harvested, washed three times with water, and resuspended to a final 
concentration of 5×10
6
cells/mL (42). Cells (1 mL) were combined with 3.5 mL of agar noble 
(1.1%) and poured as a top agar lawn onto a MLT medium agar plate. Filter disks (BD, Franklin 
Lakes, NJ) impregnated with α-factor (4, 2, 1, 0.5, and 0.25 µg/disk) were placed on the top agar. 
The plates were incubated at 30°C for 24h and then observed for clear halos around the disks. 
The experiment was repeated at least three times, and reported values represent the mean of these 
tests. 
FUS1-lacZ Gene Induction Assay 
Cells expressing Cys-less Ste2p (ICL1-Xa2) and Cys mutants were grown at 30ºC in MLT, 
harvested, washed three times with fresh medium and resuspended to a final concentration of 5 x 
10
7
 cells/mL. Cells (500 µl) were combined with α-factor pheromone (final concentration of 
1μM) and incubated at 30ºC for 90 min. The cells were transferred to a 96-well flat bottom plate 
(Corning Incorporated, Corning, NY) in triplicate, permeabilized with 0.5% Triton X-100 in 25 
mM PIPES buffer (pH 7.2) and then β-galactosidase assays were carried out using fluorescein di-
β-galactopyranoside (Molecular Probes, Inc., Eugene, OR) as a substrate as described previously 
(43). The reaction mixtures were incubated at 37°C for 60 min and 1.0 M Na2CO3 was added to 
stop the reaction. The fluorescence of the samples (excitation of 485 nm and emission of 530 
nm) was determined using a 96-well plate reader Synergy2 (BioTek Instruments, Inc., Winooski, 
VT). The data were analyzed using Prism software (GraphPad Prism version 6.02 for Windows, 
GraphPad Software, San Diego CA). The experiments were repeated at least three times and 
reported values represent the mean of these tests.  
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Binding Assays 
 Cells (LM102) expressing different receptor constructs were grown at 30C for ~20 hours at 
30C with shaking. Fifty L of cells were reinoculated into fresh medium and grown for ~16 
hours to an OD of ~1.8. Cells were washed with 15mM sodium acetate buffer, pH 4.6 containing 
sodium azide (10 mM final concentration), resuspended to a final concentration of 5 ×10
7
 
cells/ml. Cells were incubated with various concentrations of α-factor for 30 minutes at room 
temperature in the dark, washed three times with 15 mM sodium acetate buffer containing 
sodium azide (10 mM final concentration), and analyzed on a EMD Millipore (MA, USA) flow 
cytometer (Guava 6HT-2L) using excitation at 488 nm and emission at 525. The mean 
fluorescence intensity obtained at various concentrations of fluorescent α-factor analogue 
[K
7
(NBD),Nle
12
] were determined. The samples were protected from light during pre-
incubations and flow cytometry analysis. The mean fluorescence obtained from the Guava was 
analyzed by GraphPad Prism using non-linear regression analysis. Because of significant day-to-
day variation in the absolute values of the measured mean fluorescence intensity, all comparisons 
between different strains displayed in the figures show assays performed in parallel within the 
same experiment. 
Immunoblots 
 Immunoblot analysis of Ste2p was carried out as described previously (44). Cells (BJS21) 
expressing various Ste2p constructs grown in MLT were used to prepare total cell membranes as 
previously described (37,45). For studies of disulfide cross-linking, membranes were solubilized 
in SDS sample buffer (30% glycerol, 3% SDS, 0.01% bromphenol blue, 0.1875 M Tris, pH 6.8) 
without 2-mercaptoethanol. Proteins were fractioned by SDS−PAGE (10% acrylamide, 0.1% 
SDS was used in the running buffer) along with pre-stained Precision Plus protein standards 
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(BioRad) and transferred to an ImmobilonTMP membrane (Millipore Corp., Bedford, MA). 
The blot was probed with anti-FLAG™ M2 antibody (Sigma/Aldrich Chemical, St. Louis, 
MO), and bands were visualized with the West Pico chemiluminescent detection system 
(Pierce) using ChemiDoc™ XRS+ system (BioRad, Hercules, CA). The intensity of Ste2p 
signals was measured by densitometry using Image Lab™ s oftware (version 4.1, BioRad, 
Hercules, CA). Multiple repeats of immunoblot experiments yielded similar results. 
Constitutively-expressed membrane protein Pma1p was used as a loading control as described 
previously (46) using Pma1p antibody (Thermo Scientific, Rockford, IL). 
Disulfide Cross-Linking with Cu-Phenanthroline 
Disulfide cross-linking was carried out as described previously (44). One hundred µg of 
membrane protein preparation was treated with a fresh preparation (pH 7.4) of Cu(II)-1,10-
phenanthroline (Cu-P; final concentration, 2.5 μM CuSO4 and 7.5 μM phenanthroline). The 
reaction was carried out at room temperature for 20 min, terminated with 50 mM EDTA, and 
kept on ice for 20 min followed by adding SDS sample buffer without 2-mercaptoethanol. The 
membrane preparation was incubated in the absence or presence -factor (1 µM final 
concentration) for 30 min prior to Cu-P treatment in experiments performed to examine the 
influence of ligand on dimerization.  
Factor Xa digestion 
The membrane protein preparation (40 μg) was incubated with 0.4 unit of Factor Xa (Novagen) 
in Factor Xa cleavage buffer (0.1M NaCl, 50 mM Tris-HCl, 5 mM CaCl2, pH 8.0) containing 
0.1% Triton X-100 for 16h at 4C. Each sample was divided into two aliquots. The reactions 
were terminated by adding one-third the volume of Laemmli sample buffer (30% glycerol, 3% 
SDS, 0.01% bromphenol blue, 0.1875 M Tris, pH 6.8). To one aliquot β-mercaptoethanol (final 
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concentration, 1%, v/v) was added for reducing conditions. Samples were analyzed by SDS-
PAGE and Western blotting as described above. 
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Results 
Expression and Biological Activities of Cys Mutant Receptors:  
To determine intramolecular interaction between the N-terminus (NT) and extracellular 
loop 1 (ECL1) of Ste2p, one residue (Y26) in the NT and five residues (N105, S108, V109, 
Y111 and T114) in the ECL1 were chosen for mutation to Cys to investigate possible 
interactions by assaying for the formation of disulfide linkages. These residues were chosen for 
several reasons: (i) Y26 was found to be conserved in the N-terminal domains of α-factor 
pheromone receptors of the fungi Saccharomyces cerevisiae, Ashybya gossypii, Candida 
albicans, Candida dubliniensis, Candida tropicalis, Debaryomyces hansenii, Eremothecium 
cymbalariae, Kluyveromyces lactis, Lachancea kluyveri, Naumovozyma castelllii, Naumovozyma 
dairenesis, and Scheffersomyces stipits. The N-terminal regions of the α-factor pheromone 
receptors of these fungi were compared by amino acid sequence alignment. TMHMM 2.0 (47) 
was used to predict N-terminal regions and Clustal Omega (48) was used for alignment (Figure 
4.1). All twelve receptors analyzed in this study were predicted to have an N-terminal domain of 
a 45-53 residues. The multiple sequence alignment of the N-terminal domain of these receptors 
demonstrated that only two residues, Y26 and F38, in the entire N-terminus were absolutely 
conserved, (ii) Y26 was suggested to be solvent inaccessible as determined by the substituted 
cysteine accessibility method. and the Y26C mutant demonstrated a greatly increased 
dimerization in a previous study (35), (iii) Y26 is located within one of the two known 
glycosylation motifs (associated with N25 & N32) of Ste2p (34), (iv) it is located within a 
predicted beta strand in the N-terminus (35,49), and (v) mutation of residues N105, S108, V109, 
Y111 and T114 to Cys led to changes in the glycosylation pattern of the receptors, although the 
glycosylation sites are located in the N-terminus at N25 and N32 (37). 
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Figure 4.1. Sequence alignments of yeast pheromone α-factor receptors from different 
fungi. The N-terminal regions of S. cerevisiae, Ashybya gossypii, Candida albicans, Candida 
dubliniensis, Candida tropicalis, Debaryomyces hansenii, Eremothecium cymbalariae, 
Kluyveromyces lactis, Lachancea kluyveri, Naumovozyma castelllii, Naumovozyma dairenesis, 
and Scheffersomyces stipits α-factor pheromone receptors were compared by amino acid 
sequence alignment. TMHMM 2.0 (47) was used to predict N-terminal regions for 
alignment by Clustal Omega (48). Sequence conservation is shown at the bottom of the 
aligned sequences. Graphical representation (sequence logo) shows sequence conservation. 
 
To eliminate non-specific cross-linking, the template for the introduction of these 
mutations was a Cys-less receptor (37). The Cys-less template also contained two C-terminal 
epitope tags (FLAG and 6XHIS) and tandem Factor Xa cleavage sites (IEGRIEGR) in the first 
intracellular loop in order to facilitate detection of interdomain cross-linking (Figure 4.2). The 
Cys-less Ste2p-FLAG-His receptor (referred to herein as “wild-type”) and the receptor with the 
Factor Xa cleavage sites in ICL1 (referred to herein as “ICL1-Xa2”) demonstrated similar 
expression levels as well as almost identical biological activities in growth arrest and FUS1-LacZ 
assays indicating that incorporating the protease cleavage sites did not alter receptor function 
(Figure 4.3).  
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Figure 4.2. Diagram of Ste2p showing positions of Cys mutations and modifications 
introduced to facilitate disulfide cross-linking and inter- and intra-molecular interactions. 
The tandem Factor Xa protease cleavage sites engineered into ICL1 are marked with 
“XX”. The FLAG and HIS epitope tags engineered into the C-terminus are also shown. 
The two endogenous Cys residues (C59 and C252 – hatched circles) were mutated to Ser to 
generate Cys-less Ste2p. The sites of Cys mutation engineered into into the NT and ECL1 
regions for disulfide cross-linking (Y26C, N105C, S108C, V109C, Y111C and T114C) are 
shown in grey circles. The two known glycosylation sites are shown with “ψ” symbol. 
151 
 
 
Figure 4.3. Comparison of the expression levels and signaling activities of the WT and 
ICL1-Xa2 receptor used in this study. ICL1-Xa2 is the Cys-less receptor containing the C-
terminal FLAG and His epitope tags and a tandem Factor Xa digestion site in IL1. Wild-
type is the Cys-less receptor without the Factor Xa digestion site containing the FLAG and 
His epitopes. (A) total membranes prepared from the cells expressing  wild-type and ICL1-
Xa2 constructs were immunoblotted using anti-FLAG antibody. The bottom panel shows 
the same immunoblot re-probed using antibody against Pma1p, a constitutively expressed 
plasma membrane protein used as a loading control. (B) The zone of growth inhibition of 
strains carrying the indicated receptors was measured at various concentrations of α-
factor. (C) Signaling activities of the constructs determined by pheromone-induced FUS1-
LacZ activity. The grey bars represent the constitutive signaling and the black bars 
represent the α-factor induced signaling activity. The signaling was normalized to that of 
the wild-type construct. 
The signaling activities of the cysteine mutants were examined by pheromone-induced 
growth arrest and FUS1-LacZ induction assays. The growth arrest assay is a sensitive test that is 
used to determine the ability of cells expressing Ste2p to maintain pheromone-induced cell 
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division arrest over a period of 24h. The FUS1-LacZ induction assay, on the other hand, 
measures an early response of the yeast cell to pheromone. The strains used in this study were 
engineered with a reporter gene construct consisting of a fusion between FUS1 promoter and the 
lacZ gene encoding the enzyme β-galactosidase (50). The FUS1-LacZ assay allows for fast, 
sensitive detection of mating pathway activation by assessing the induction of β-galactosidase 
activity in response to mating pheromone. The growth arrest activity of the mutants varied from 
33-90% of the ICL1-Xa2 control whereas the FUS1-LacZ activity varied from 30-90% of the 
ICL1-Xa2 control (Table 4.1). It was noticed that growth arrest activity and FUS1-LacZ activities 
of some mutants were different. For example, S108C exhibited 65% growth arrest compared to 
the ICL1-Xa2 control and 30% FUS1-LacZ activity. The Y26C/V109C exhibited 34% growth 
arrest activity and 72% FUS1-LacZ activity. The difference between the FUS1-LacZ activity and 
cell division arrest (growth arrest activity) has been observed in many studies and has been 
explained on the basis of the amount of time after pheromone exposure when the response was 
measured (51-53).  
 
 
 
 
 
 
 
153 
 
Table 4.1. Biological activities of Cys mutant receptors 
1
Relative halo size was compared to the halo size of the ICL1-Xa2 receptor at 1 µg of α-factor 
applied to a disc. The standard deviation of the halo activity for all receptors was within ±0.1 
(three replicates). 
2
Relative activity (±standard deviation) compared with basal activity of the ICL1-Xa2. 
3
Relative activity (±standard deviation) compared with induced activity of the ICL1-Xa2 at 1 µM 
of α-factor. 
 
Receptor  
  
  
Growth arrest 
activity
1
 
β-galactosidase activity 
Basal 
Activity
2
 
Induced Activity
3
 
ICL1-Xa2 1.00 1.00±0.16 1.00±0.05 
Y26C 0.60 1.12±0.10 0.53±0.03 
N105C 0.79 0.97±0.18 0.43±0.01 
Y26C/N105C 0.40 1.04±0.16 0.47±0.04 
S108C 0.65 1.01±0.14 0.30±0.02 
Y26C/S108C 0.59 0.97±0.21 0.45±0.02 
V109C 0.84 0.95±0.12 0.89±0.01 
Y26C/V109C 0.34 0.97±0.05 0.72±0.02 
Y111C 0.90 0.97±0.04 0.30±0.01 
Y26C/Y111C 0.70 0.94±0.04 0.64±0.01 
T114C 0.87 1.00±0.04 0.57±0.01 
Y26C/T114C 0.75 0.98±0.01 0.39±0.02 
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The expression level of each single and double-Cys mutant receptor was determined by 
Western blot analysis. All mutant receptors showed several bands between 44 and 55 kDa 
(Figure 4.4A). The multiple bands are typical of Ste2p expression and are due to differences in 
the glycosylation state, which does not influence receptor function (34). Although the two 
intrinsic Cys residues have been substituted, a weak band at ~110 kDa, corresponding to a 
dimerized form of Ste2p, was observed for the ICL1-Xa2 receptor. This band is likely a native, 
noncovalent dimer which was not disrupted by membrane protein preparation or SDS-PAGE. 
Such dimers have been observed on SDS-PAGE gels in our lab (35,43,44,54) and those of others 
working with Ste2p (49,55,56). Although the Cys constructs were expressed as judged by the 
Western blot, there was a large variability in the amount of receptor expressed, the glycosylation 
pattern, and the distribution of monomer to dimer among these mutants (Figure 4.4A).  
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Figure 4.4. (A) Ste2p expression levels of various Cys mutants. Whole cell lysates from cells 
expressing various mutants were prepared as described in Materials and Methods. The cell 
lysates were run on SDS-PAGE gel under non-reducing conditions; the gel was blotted and 
probed using antibody against the C-terminal FLAG epitope tag to detect the presence of 
Ste2p at either the monomer or dimer positions, (B) Effect of reducing agent (β-
mercaptoethanol) on dimerization. Cell lysates prepared from cells were run on SDS-
PAGE under reducing conditions; the gel was blotted and probed with anti-FLAG 
antibody to detect the presence of Ste2p at either the monomer or dimer positions, (C) 
Effect of ligand binding on dimerization. Cell lysates were incubated with -factor (1µM 
final concentration); the membrane extracts were run on SDS-PAGE gel under non-
reducing conditions; the gel was blotted and probed with anti-FLAG antibody to detect the 
presence Ste2p at either the monomer or dimer positions. Molecular mass markers (kDa) 
are indicated on the left-hand side. 
 
156 
 
 
157 
 
The N-terminal Cys Mutant Y26C Forms Dimers:  
Ste2p is observed on immunoblots predominantly as a monomer of about 50 kDa as most 
non-covalent interactions between receptors are disrupted by the conditions of the SDS-PAGE.  
However, some SDS-resistant dimers persist as had been observed in many studies 
(37,43,44,55,57,58). Consistent with the previous studies, Ste2p was observed predominantly as 
a monomer at about 50 Kda with a small amount SDS-resistant dimer at about ~110 kDa in our 
Cys-less construct ICL1-Xa2 (Lane ICL1-Xa2, Figure 4.4A). On the other hand, Y26C exhibited 
a strong dimer with a small amount of monomer (Lane Y26C, Figure 4.4A). The single Cys 
mutants N105C, S108C, V109C, Y111C and T114C showed predominantly as a monomer with a 
small amount of dimer. Additionally, with the exception of V109C, Ste2p banding pattern in the 
other single Cys mutants was different from the ICL1-Xa2 control as exhibited by diffuse bands 
between ~55 and ~70 Kda. The diffuse banding pattern was attributed to changes in the 
glycosylation pattern of the receptors as these bands collapsed into a major monomeric band 
upon treatment with PNGase (37). The Ste2p expression levels of these mutants were also 
weaker than that of the ICL1-Xa2 when the loading control (not shown) is taken into account. 
The low expression level of the ECL1 single mutants (N105C, S108C, Y111C, and T114C) was 
also observed previously (37).  The expression levels of the double Cys mutants were also 
weaker than that of the ICL1-Xa2 when the amount of protein loading is considered (Figure 
4.4A). The banding pattern of the double Cys mutants was also different from the ICL1-Xa2 as 
exhibited by a strong band (at about 50 Kda) along with a small amount of diffused bands 
between ~50 and ~70 Kda. Since the diffused banding pattern was not observed in Y26C and 
observed in N105C, S108C, Y111C and T114C, the differential banding pattern in the double 
Cys mutants can be attributed to mutations in ECL1.  
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The majority of the double Cys mutants exhibited stronger dimer with weaker monomer 
as compared to those of the ICL1-Xa2 under non-reducing condition (Figure 4.4A). As stated 
above, the ICL1-Xa2 and virtually all of the single Cys mutants of Ste2p exhibited no or faint 
bands at about 110 kDa consistent with a small amount of dimerized Ste2p. Since strong dimer 
was demonstrated in the majority of the double Cys mutants containing Y26C and weak dimer in 
the corresponding single Cys mutants, the dimers formed by these mutants can be attributed to 
Y26C. The dimer bands at ~110 kDa of the all the double Cys mutants decreased by the addition 
of β-mercaptoethanol indicating the involvement of disulfide bonds in stabilization of the dimer 
(Compare Figure 4.4A & B; See Table 4.2).  
Analysis of the ratio of dimer to monomer in the gels under non-reducing conditions 
showed that the dimer/monomer ratio of Y26C was ~28 fold greater than that of the ICL1-Xa2 
control, whereas that of the double Cys mutants (Y26C/N105C, Y26C/S108C, Y26C/V109C, 
Y26C/Y111C and Y26C/T114C) ranged from about 4- to 8-fold greater (Table 4.2). The dimer 
ratio of the single Cys mutants ranged from 2-4 fold greater than that of the ICL1-Xa2 control. 
Under reducing conditions, the dimer to monomer ratio of the Y26C and all the double Cys 
mutants decreased significantly (p<0.05), whereas the ratio did not change in any of the other 
single Cys mutants suggesting that the dimerization in the double Cys mutants were maintained 
by Y26C.  No significant difference was observed in the ratio of dimer to monomer ratio among 
Y26C/N105C, Y26C/S108C and Y26C/Y111C. Also no significant difference in the ratio was 
observed between the Y26C/V109C and Y26C/T114C. These results indicate that the 
dimerization by Y26C is affected by mutation at positions V109C and T114C, whereas mutation 
at other positions did not affect dimerization.  
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Table 4.2.  Dimer to monomer ratio of Cys mutants in non-reducing and reducing 
conditions 
1
Relative dimer to monomer ratio of the Cys mutants as compared to that of the ICL1-Xa2 in the 
absence of -ME. 
2
Relative dimer to monomer ratio of the Cys mutants as compared to that of the ICL1-Xa2 in the 
presence of -ME.  
Significant difference (p<0.05)) in dimer to monomer ratio of the receptors in non-reducing and 
reducing conditions is indicated by “*”. The dimer to monomer ratio of the mutants of the all the 
mutants was normalized to that of the ICL1-Xa2. The standard deviation of the relative dimer to 
monomer ratio for all receptors was within ±0.6. 
 
 Receptor Non-reducing
1
 Reducing
2
 
ICL1-Xa2 1.0 1.0 
Y26C* 27.9 12.3 
N105C 2.2 2.3 
Y26C/N105C* 8.0 5.9 
S108C 3.1 2.3 
Y26C/S108C* 8.3 4.4 
V109C 3.7 2.2 
Y26C/V109C* 5.7 3.4 
Y111C 4.4 3.2 
Y26C/Y111C* 8.2 4.5 
T114C 1.9 1.3 
Y26C/T114C* 4.1 2.6 
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Conformational Changes in the N-terminus Upon Ligand Binding: It is generally believed that 
activation of GPCRs upon ligand binding results in a conformational change involving 
rearrangement of the various receptor domains (59-62). Previous studies have also shown that 
binding of -factor affected Ste2p dimer formation (36,44,58). Additionally, the N-terminus of 
Ste2p was reported to be involved in dimerization in several studies (35,36). A commonly used 
method to examine ligand-induced conformational change in GPCRs is disulfide cross-linking 
involving cysteine-substituted mutant receptors. This strategy can be used to determine the 
differences in disulfide formation between two receptor monomers containing Cys residues in 
the presence and absence of ligand (58,63,64). We investigated whether incubation with -factor 
would influence dimerization of the mutants examined in this study. We observed that dimer 
formation by the ICL1-Xa2 control and majority of the mutants was not affected by agonist. 
However, three mutants (Y26C, Y26C/N105C and Y26C/S108C) exhibited a significant 
difference in the ratio of dimer to monomer in the absence or presence of agonist (Compare 
Figure 4.4A & C; see Figure 4.5). The dimer to monomer ratio of Y26C significantly decreased 
upon incubation with α-factor. On the other hand, the dimer to monomer ratio of Y26C/N105C 
and Y26C/S108C increased significantly. These results suggest that -factor binding induces 
conformational changes in the N-terminus and EL1 of Ste2p which alters the availability of the 
Y26C, Y26C/N105C and Y26C/S108C residues for cross-linking, whereas for the other mutants 
of the ECL1 dimerization is not affected by ligand binding. These results indicate that the dimer 
interface formed by the N-terminus of the receptor changes upon receptor activation.  
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Figure 4.5. Effect of ligand binding on dimerization. Band intensity of dimer and monomer 
forms of Ste2p was quantified from Western blots (Figure 4.4A & C) using Image Lab 
(version 4.1). The dimer/monomer ratio of the mutants was normalized to that of the ICL1-
Xa2. Black and grey bars represent the ratio of dimer to monomer in the absence or 
presence of -factor, respectively. Statistical significance (p<0.05) in the dimer-monomer 
ratio is indicated by an asterisk.  
162 
 
Determination of intramolecular interaction between N-terminus and extracellular loop 1: 
The experiments described above indicated that dimerization mediated by Y26C was hindered by 
the V109C and T114C mutations in ECL1 suggesting a possible interaction between Y26C and 
these two positions in Ste2p. To test this idea, we took advantage of the protease (Factor Xa) 
digestion site engineered into ICL1 of Ste2p. If cross-linking between Y26C and V109C or 
T114C occurred, subsequent Factor Xa digestion would yield a full-length receptor, which can 
be detected by antibody against the C-terminal FLAG epitope tag (Figure 4.6, right panel). In 
contrast, if cross-linking did not occur, the receptor would be cut into two fragments, and a 42 
kDa band would be detected on immunoblots using the C-terminal FLAG antibody (Figure 4.6, 
left panel). As expected, digestion of ICL1-Xa2 receptor with Factor Xa led to detection of a 42 
kDa fragment, and this digestion also lowered the total amount of Ste2p detected in both the 
monomer and dimer (non-disulfide) form(compare lanes 1 and 2 in Figure 4.7A) . In contrast, the 
42 kDa fragment protease digestion fragment was not detected in Y26C/V109C and 
Y26C/T114C mutants (lanes 4 and 6 in Figure 4.7A). Similar results were obtained when the 
receptors were incubated without (lanes 1-6) or with α-factor (lanes 7-12) before digestion with 
Factor Xa. The monomer bands (~55 kDa) are due to incomplete Factor Xa digestion. We 
performed partial digestion because a longer incubation led to degradation of proteins. 
To ascertain if the interaction was indeed due to disulfide cross-linking, all of the 
receptors showed the 42 kDa band, when treated with a reducing agent (-mercaptoethanol) after 
protease digestion in both the presence and absence of α-factor (Figure 4.7B).  These results 
demonstrate that Y26 in the extracellular N-terminus and V109 and T114 in ECL1 of Ste2p 
molecule are in close proximity and provide evidence that the N-terminus and ECL1 may 
interact via these contacts. 
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Figure 4.6. Diagram showing the schematic of determination of intramolecular interaction 
using protease Factor Xa digestions followed by immunoblot detection using antibody 
against the C-terminal FLAG epitope tag. Non-reducing and reducing conditions of the 
sample buffer is indicated by NR and R respectively. The diagram of immunoblot on the 
left shows no interaction and the diagram of the immunoblot on the right shows a positive 
interaction. The N and C-termini of Ste2p are indicated by N and C, respectively. The 
green in ICL1 indicates the location of the protease Factor Xa cleavage site. The FLAG and 
His (6) epitope tags are shown in black. 
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Figure 4.7. Factor Xa digestion. Membranes prepared from cells expressing the indicated 
receptors were prepared and digested as described in Materials and Methods. The samples 
were separated by SDS-PAGE in non-reducing (A) and reducing (B) conditions. The 42 
kDa Ste2p fragment detected is marked with an arrow. The molecular markers are shown 
on the left.  
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Discussion 
 
We herein present data indicating a role for a highly conserved tyrosine residue in the N-
terminus of Ste2p in dimerization and interaction with ECL1. Specifically, we identified Tyr26 
as a key residue that is important for Ste2p dimerization facilitated by two residues Val109 and 
Thr114 in ECL1. Furthermore, using disulfide cross-linking methodology, we provide evidence 
that Tyr26 interacts with Val109 or Thr114. We also present data suggesting that the N-
terminus-mediated dimer interface of the receptor changes upon receptor activation. The 
disulfide cross-linking studies were carried out with Ste2p in its membrane-bound state. The 
maximum distance between α-carbons linked by disulfide bonds was shown to be about 7Å (65). 
Thus, these experiments should identify amino acid side chains that are within this distance. 
Cysteine residues engineered into GPCRs has been applied to facilitate disulfide bond formation 
in several GPCRs including Ste2p (44,54,58,61,66-69).  
It had been suggested that the N-terminus of Ste2p is involved in dimerization (35,36). 
Our results support these findings and furthermore identified a specific residue in the N-terminus 
that facilitates Ste2p dimerization. The mutant receptor Y26C showed significantly increased 
dimerization over that of the ICL1-Xa2 (Figures 4A, 4B & Table 4.2). The finding that Y26C 
participates in dimer formation is in good agreement with the recently published results that 
Y26C is inaccessible to the sulfhydryl reagent MTSEA-Biotin (35) since the Y26C-Y26C 
interaction might render Y26C inaccessible. The fact that this residue formed a linkage suggests 
that the Ste2p-Ste2p interactions involving this region of the N-terminus have significant spatial 
restrictions which might make this region relatively rigid. This is consistent with the prediction 
that this region of the receptor has a β strand (35,70,71). Thus our mutational analysis defines a 
specific residue (Y26C) that appears to be involved in Ste2p dimerization. 
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  It is interesting that N-terminus-mediated dimerization was hindered by mutations in the 
ECL1 of the receptor. This is consistent with the idea that the N-terminus interacts with 
extracellular loop 1. It had been shown previously that mutations in ECL1 affected the 
glycosylation pattern of the receptor (37), although the glycosylation sites are located in the N-
terminus (34). The mutant receptors Y26C, Y26C/N105C, Y26C/S108C, Y26C/V109C, 
Y26C/Y111C and Y26C/T114C exhibited markedly increased dimerization over that of the 
ICL1-Xa2 (Figures 4A, 4B & Table 4.2). The dimerization of these mutants was reversed by 
treatment with β-ME. On the other hand, the single Cys mutants (N105C, S108C, V109C, 
Y111C and T114C) exhibited weak dimerization as compared to the mutants containing Y26C 
mutation (Figures 4A, 4B & Table 4.2) and no significant decrease in dimerization was observed 
when treated with β-ME, indicating that the small amount of dimers formed by these mutants 
was due to SDS-resistant association between receptors that is not mediated by disulfide bonds. 
Out of the five double Cys mutants tested, two mutants (Y26C/V109C and Y26C/T114C) 
exhibited decreased dimerization as compared to the other three (Y26C/N105C, Y26C/S108C 
and Y26C/Y111C) indicating that Y26C-mediated dimerization was prevented by mutations at 
positions V109C or T114C. These results are consistent with the idea that interaction of Y26C 
with either V109C or T114C will hinder Y26C-Y26C interaction thus reducing dimerization. On 
the other hand, the other positions (N105C, S108C, Y111C) do not interact with Y26C and thus 
Y26C-Y26C interaction is not affected thereby dimerization maintained by Y26C does not 
change. These results suggest that Y26C interacts with these two positions. Since Y26C is 
located adjacent to a glycosylation site (N25), it is expected that mutations blocking the 
interaction might influence the glycosylation pattern. Indeed, it was observed previously that 
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mutation in these positions affect the glycosylation pattern (37). Thus these findings suggest that 
Y26 interacts with V109 and T114. 
 It is important to note that reduced dimerization of Y26C/V109C and Y26C/T114C might 
result from non-specific effects of mutation rather than interaction between the N-terminus and 
ECL1. To ascertain if specific interactions between Y26C and the two residues in ECL1 existed, 
we used disulfide cross-linking followed by Factor Xa digestion. We found that these two 
residues (V109C and T114C) in EL1 indeed cross-link with Y26C (Figure 4.8). This strategy has 
been used previously in our lab to determine the involvement of TM regions in dimerization 
(44).These results support previous studies in which mutation T114C along with N105C, S108C, 
and Y111C was found to change glycosylation pattern of the receptor. Our study identified the 
specific residues in EL1 and N-terminus that interact with each other. This finding led us to 
believe that the N-terminus and EL1 are in close proximity and these two domains have strong 
interactions that might play an important role in negative regulation of signaling as discussed in 
chapter 3 of this dissertation. 
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Figure 4.8. Ste2p dimer mediated by Y26 and its interaction with ECL1. Two Ste2p 
molecules (orange and green) are shown with the positions of Y26 (green and orange dots), 
V109 (black) and T114 (black). Intramolecular and intermolecular interactions are shown 
on the left and right panels, respectively. 
 
 The finding that NT is involved in Ste2p dimerization led us to propose that at least four 
dimerization interfaces can exist in Ste2p. In addition to the TM1, TM4, TM7 interfaces 
previously found (36,44,58), our data suggest that NT-NT interactions are also involved in direct 
contacts in the Ste2p dimer. The results described in this study show that cysteine residue 
introduced in the N-terminus (NT) forms a disulfide bond with its counterpart in another Ste2p 
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monomer (Figure 4.8). Since Y26C-mediated dimerization is prevented by Cys mutations at 
V109 and T114, these two residues in ECL1 are in close proximity to Y26C in the receptor.  
These results also suggest that the distance between Y26C and V109C or T114C is closer than 
that of Y26C of another Ste2p molecule in a Ste2p dimer mediated by Y26C-Y26C interaction 
because introduction of Cys at these positions competes out Y26C-Y26C interaction. It is also 
possible that Y26C-mediated dimerization was prevented by intermolecular interaction between 
Y26C of one Ste2p molecule with V109C or T114C of a second Ste2p molecule.  
We also report here that the N-terminus of Ste2p is a dimer interface that changes upon 
receptor activation. Specifically, dimerization of Y26C, Y26C/N105C, and Y26C/S108C was 
found to change in the presence of α-factor. The dimerization mediated by Y26C was found to 
decrease in the presence of α-factor indicating that the dimer interface at the N-terminus of the 
receptor moves away from each other during receptor activation. The movement of the N-
terminus may affect other domains of the receptor including ECL1 and TM domains which are 
believed to be involved in receptor activation. On the other hand, the dimerization mediated by 
Y26C/N105C and Y26C/S108C mutants was found to increase suggesting that the dimer 
interface mediated by Y26C moves closer to each other. Previous studies in our lab demonstrated 
that solvent accessibility of several residues (Y101, Y106, and A112) in ECL1 changes upon 
incubation with α-factor thereby indicating the involvement of this region in receptor activation 
(37). A 310 helix was also predicted between residues 106-114 in the ECL1.Our results suggest 
that Y26 interacts with two residues (V109 and T114) in this region that are part of the 310 helix. 
It is possible that in the presence of α-factor, the N-terminus moves away due to conformational 
changes in the ECL1 thereby affecting Y26-mediated dimerization. On the other hand, N105 and 
S108 are adjacent to these interacting residues in ECL1 (V109 and T114). Thus changes in these 
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two residues (N105 and S108) may influence the conformation of the ECL1 thereby affecting 
dimerization of Y26C/N105C and Y26C/S108C receptors, resulting in increased dimer 
formation due to bring the Y26 closer to each other.  
GPCRs have been believed to exist and function as monomers for many years. 
Nevertheless, a growing number of studies demonstrated that GPCRs form dimers or higher-
ordered oligomers, which have been proposed to be essential for modulation of receptor function 
(1,63,72-77). In most receptors, the transmembrane domains were reported to be involved in 
receptor dimerization/oligomerization. However, several studies demonstrated the extracellular 
N-terminal domain of Ste2p is also associated with dimerization (35,36). The residue identified 
in this study, Y26C, is highly conserved in fungal GPCRs. Conserved residues are often 
important for structure and function of proteins and conservation is stronger at protein-protein 
interfaces compared to elsewhere on the protein surface (78-81). Thus analysis of sequence 
conservation in a protein family is a useful strategy to identify key residues that are important for 
protein function (82-91). Protein-protein interaction sites are subjected to substantial selective 
pressure to maintain critical interactions throughout the course of evolution (92,93).  
These findings provide valuable information relating to the arrangement of the receptor in which 
the N-terminus appear to face each other. In the absence of a crystal structure for Ste2p, the 
disulfide cross-linking results contributes to understanding structural features of the functional 
receptor such as inter-amino terminal interactions that may be involved in oligomerization. 
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Chapter 5  
Conclusions, summary and future studies 
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Summary 
 
This dissertation describes the identification of a discrete structure that is involved in 
homodimer formation of Ste2p, the yeast α-factor receptor, a model system for mammalian 
GPCR peptide hormone receptors. The Substituted Cysteine Accessibility Method (SCAM) was 
used to determine the accessibility of residues in the N-terminus and disulfide cross-linking was 
used to determine dimer formation by these residues. These studies revealed that certain residues 
in the extracellular N-terminus were solvent inaccessible and that these residues also promote 
increased dimers formation. The pattern of accessibility combined with the disulfide cross-
linking results suggested the presence of a β-strand structure in the N-terminus which was 
predicted previously by bioinformatics analysis of this region. Deletion mutagenesis revealed 
that the N-terminus is involved in negative regulation of signaling. Further analysis of the N-
terminus revealed that a conserved tyrosine residue in the βstrand plays a critical role in receptor 
dimerization and likely interacts with two residues (V109 and T114) in ECL1 of the receptor. 
Furthermore, the Ste2p dimer interface was found to change upon receptor activation thereby 
supporting the emerging idea that dimerization plays an important role in receptor function. 
The Substituted Cysteine Accessibility Method (SCAM) was used to determine the 
accessibility of residues in the N-terminus and disulfide cross-linking was used to determine if 
the N-terminus is part of a dimer interface for Ste2p. The results of these assays indicate that 
certain residues in a short segment of the N-terminus of Ste2p do not react with a water-soluble 
biotinylation reagent and appeared to be involved in receptor dimerization. Interestingly, the 
pattern of solvent accessibility was found to be consistent with a β-sheet-like structure involving 
the stretch of residues G20-Y30. It was also found that the dimer interface changed in response 
to pheromone indicating a change in conformation of the N-terminus upon receptor activation. 
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These findings suggest that the N-terminus of Ste2p possesses a discrete structural domain that 
appears to participate in the signaling mechanism. Interestingly, a β-strand was predicted in this 
region by sequence analysis (1,2).  
Deletion mutagenesis demonstrated that the N-terminus constrains Ste2p signaling activity. 
The N-terminus of GPR56, an adhesion GPCR, has also been reported to constrain receptor 
activation (3). Previous studies with Ste2p demonstrated a role of the N-terminus in dimerization 
(4-6), mating (1,2) and as a site of glycosylation domains(7). Our studies revealed a previously 
unrecognized role of the N-terminus: the constraint of signaling activities by stabilizing the 
inactive state of the receptor.  The proposed interaction between the N-terminus and other 
domain(s) of the receptor may function to stabilize the inactive state of the receptor. Thus, 
removal of portions of the N-terminal domain may affect Ste2p dimerization or interaction with 
other domain(s) of the receptor that is important for activation (4,5). In fact, the β-sheet like 
contacts found in the N-terminus may help to maintain the receptor in its inactive conformation 
and removal of these residues would thereby facilitate transition to an activated state upon ligand 
binding. Previous studies indicated a possible interaction between the N-terminus with the 
extracellular loop one (ECL1), based on changes in glycosylation pattern of the receptor which 
were observed upon mutation of residues in ECL1, although glycosylation sites are located in the 
N-terminus (8).  
An evolutionarily conserved tyrosine residue, Y26, in the N-terminus was found to play key 
role in receptor dimerization. Two residues in the ECL1 (V109 and T114) facilitate Y26-
mediated dimerization. The disulfide cross-linking studies indicated that Tyr26 interacted with 
Val109 or Thr114. The dimer interface of the receptor was found to change in response to 
pheromone indicating a role for dimerization mediated by the N-terminus in receptor activation. 
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Because the maximum distance between α-carbons linked by disulfide bonds is about 7Å (9), the 
amino acid side chains identified using this methodshould be very close (within 7Å). This 
strategy has been used to identify interacting residues in several GPCRs including Ste2p (10-17).  
Future studies 
 
Despite the remarkable progress made in the structural biology of GPCRs, a clear 
understanding of the extracellular N-terminus and its significance in signal transduction remains 
ambiguous. In addition, although dimerization is a widely observed phenomenon in GPCRs, the 
functional significance of this phenomenon for the vast majority of GPCRs is still debated. The 
results obtained during the course of the studies for this dissertation will aid in understanding the 
role of the N-terminus and dimerization in GPCR signal transduction. However, in order to fully 
understand the role of this extracellular domain and dimerization in receptor function, further 
studies are necessary. A few suggestions are outlined below to elucidate the role of the Ste2p N-
terminus and dimerization. 
The results obtained in Chapter 2 indicate that SCAM was useful in determining the 
accessibility of residues in the extracellular N-terminus. Although these experiments revealed the 
accessibility of residues in the inactive state of the receptor, it is not known whether the 
accessibility of these residues is changed upon receptor activation. This information is important 
since conformational changes also occur in the N-terminus upon receptor activation as indicated 
by changes in dimerization in the absence and presence of α-factor, Therefore, SCAM studies of 
the residues in the presence of α-factor will provide information regarding conformational 
changes in the N-terminus that leads to receptor activation.  
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The results described in Chapter 3 of this dissertation indicate that removal of the N-
terminus affects signaling and surface expression. However, no specific residue(s) in the N-
terminus was identified as being most responsible for this effect. Alanine scanning mutagenesis 
in this region might reveal the specific residue(s) responsible for signaling and/or surface 
expression. Furthermore, the N-terminus was suggested to be involved in negative regulation but 
the mechanism of the regulation is still unknown. The N-terminus possesses two glycosylation 
sites located at N25 and N32. A previous report indicated that mutation of these two 
glycosylation sites to glutamine did not influence receptor function. However, our studies with 
Cys mutation in the glycosylation sites indicate that signaling activity was altered. Thus it 
appears that glycosylation in the Ste2p affects signaling but a thorough investigation of the role 
of this post-translational modification on receptor function is warranted. For example, three 
forms of receptor mutants having none, one or two glycosylation sites can be tested for 
functional properties to determine if glycosylation plays a role in receptor function.   
Disulfide cross-linking studies demonstrated that a conserved tyrosine residue (Y26) in the 
N-terminus interacts with V109 or T114 in ECL1. However, these experiments were carried out 
using membranes prepared from cells expressing these receptors. Thus it is not known if the 
interaction also occurs in whole cells. Therefore, cross-linking studies using whole cells can be 
done to determine the interaction in vivo. The Y26C mutant functions as a major dimer interface 
for Ste2p, and exists as a dimer even in the absence of pheromone. The Y26C mutant exhibited 
weaker growth arrest activity compared to that of the wild type. On the other hand, Y26A mutant 
does not form promote dimerization, but exhibits increased signaling activity suggesting that 
dimerization prevents signaling. Although the growth arrest activity of the Y26C and Y26A 
mutants was similar, FUS1-LacZ activities of the Y26A mutant was higher indicating that signal 
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transduction by dimer and monomer is different. Conformational changes in the receptor 
resulting from the activation of a Ste2p dimer may be different from that of the monomer thereby 
initiating a signal. SCAM and disulfide cross-linking can be used to understand the 
conformational changes which occur in the dimerized receptor in response to pheromone. 
Identification of the residues and domains that are involved in GPCR dimerization might 
establish the foundation for the design of drugs that specifically affect the signaling crosstalk 
between the components of the receptor dimer/oligomer.  
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